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1. PREFACE 
1.1. Viruses 
In 1892, Dmitri Iosifovich Ivanovsky, by employing Chamberland filter which 
had pores smaller than the size of bacteria, was able to demonstrate the 
existence of non-bacterial infectious agents, which in the later time came to be 
known as 'viruses'. However, the word 'virus,' which was apparently derived 
from Sanskrit, has an overall meaning of negativity comparable to 'wiesel' in 
German, 'weasel' in English or 'vison' in French, all of which refer to an animal 
that sprays a strong fluid when threatened. Whatever might be the origin of this 
important word since its foundation, the science now called 'virology' has been 
expanded and has travelled a great distance (1–3). In the simplest terms, viruses 
can be described as small obligate parasites with an RNA or DNA genome 
surrounded by a protective coat (4, 5).  
These tiny sub-microscopic entities are found throughout the ecosystem, 
including under extreme conditions of temperature and solvent medium (6). For 
example, it has been proposed that the ocean contains approximately 1031 virus 
particles; these particles contribute close to 20% of oceanic biomass production 
per day. If these number of viruses could be placed side by side, it could easily 
cross nearest 60 galaxies to the planet Earth (7). As viruses can invade any form 
of life starting from archaea to prokarya to eukarya, they represent a very 
significant repository and combination of genetic diversity (2, 6). 
 
 
1.2. Classification of viruses  
The rules set by the International Committee on Taxonomy of Viruses (ICTV) 
along with the Baltimore system are primarily used to classify viruses at the 
present time (8, 9). The ICTV system guides the classification starting from 
order, family, subfamily, genus to species level, while the Baltimore classi-
fication system is based on the basic viral strategy to produce mRNA from the 
genetic material of the virus (8, 9). According to the Baltimore classification, 
viruses are classified into seven different groups as follows (Fig. 1).  
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Figure 1. Baltimore classification of viruses according to their genetic material; adapted 
from http://viralzone.expasy.org (8).  
 
 
1.3. Size of viruses 
Viruses have evolved with amazing diversity in their size and shape. They range 
from as small as 20 nm to as large as 1000 nm in size, while their shapes are 
equally astonishing. For example, there are filamentous viruses such as Ebola 
virus, helical viruses such as Tobacco Mosaic Virus, icosahedral viruses such as 
rhinovirus and complex shapes such as T7 bacteriophage could be put forth. 
However, due to the focused nature of the current thesis, I have tried to very 
briefly outline the average sizes of some of the most common viruses to 
compare their relatively miniature natures (Table 1). 
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Sr No.  Resolution of   Average Size 
(nm) 
1  Human eye  >100,000 
2  Light microscope  200 
3  Electron 
microscope 
 2 
Ref. http://www.biology.arizona.edu/cell_bio/tutorials/cells/cells2.html 
Sr No.  Size of   Average Size 
(nm) 
4  Plant cell  100,000 
5  Animal Cell  10,000 
6  Bacterial cell  1000 
7  Length of an aa  0.34 (10) 
Ref. http://www.biology.arizona.edu/cell_bio/tutorials/cells/cells2.html 
Sr No. Family Representative 
member 
Associated 
Disease 
Average Size 
(nm) 
8 Pandoravirida Pandoravirus None yet 1000 (11)  
9 Mimiviridae Mimivirus None yet 800 (12) 
10 Poxviridae Variola virus Smallpox 200–300 
11 Paramyxoviridae Measles virus Measles 80–250 
12 Herpesviridae Herpesvirus Herpes 150–160 
13 Rhabdoviridae Rabies virus Rabies 70–180 
14 Coronaviridae CoV SARS 80–160 
15 Adenoviridae Adenovirus Common cold 70–80 
16 Reoviridae Rotavirus Diarrhea 60–80 (13) 
17 Togaviridae Rubella virus Rubella 60–80 
17 Papillomaviridae Human 
papillomavirus 
Cervical 
cancer 
40–60 (14) 
18 Hepadnaviridae Hepatitis B virus Hepatitis B 42 
19 Picornaviridae Poliovirus Polio 20–30 
20 Parvoviridae Parvovirus Fifth disease 18–22 (15) 
Ref. http://www.elu.sgul.ac.uk/rehash/guest/scorm/343/package/content/size.htm 
Table 1. Viruses show amazing diversity in their sizes.  
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2. INTRODUCTION 
Chikungunya Virus (CHIKV), a representative member of the Alphavirus 
genus, is a relatively small RNA virus which is primarily transmitted to humans 
by mosquitos and causes high fever, skin rash, headache, muscle pain and 
polyarthralgia. Currently there is no approved therapeutics or vaccines against 
this pathogen. Furthermore, the current level of understanding regarding the 
mechanisms of infection and hijacking of the host cell machinery is broadly 
drawn from studies of Old World alphaviruses such as SINV, SFV, which are 
similar but certainly not identical to CHIKV. 
The nonstructural proteins (nsPs), which are the prime gears of CHIKV, are 
the main components that empower the virus to ensure the establishment of 
RNA replication machinery inside the host cell and channel or modulate host 
cell resources to support viral replication to complete a successful cycle of in-
fection. However, the roles of individual ns proteins are still very incompletely 
understood; in consequence, our understanding of the overall replication of this 
highly medically important virus is clearly inadequate. Moreover, it is apparent 
that the isolated individual ns proteins could behave differently than their 
counterparts inside finely calibrated and highly sophisticated replication com-
plexes. Characterizing the biochemical and biological functions of the nsPs in 
these two entirely different settings is essential to understand and analyze the 
regulation of their enzymatic activities. Along with biophysical and structural 
approaches, these strategies could lead towards the ultimate goal of cultivating 
an understanding the molecular alterations occurring in these greatly organized 
macromolecular productive assemblies, and characterization of which is inevi-
tably required to understand the overall molecular biology underlying virus 
replication. In this thesis, I summarize several studies that aimed to biochemi-
cally and biophysically address some of these aspects of viral enzymatic pro-
teins in a relatively comprehensive and fine-tuned manner. 
Out of the four ns proteins, nsP2 is exceedingly multitalented. It not only 
harbors a number of vital enzymatic functionalities for assisting the viral RNA 
replication but also represents quite possible determinant of the cytopathic 
properties of the virus. Thus, the aim of these studies was to biochemically 
analyze the properties of this protein in relation to RNA modulation, one of the 
leading functions of this comparatively large viral protein, in the context of a 
biochemically purified recombinant protein. Furthermore, an attempt was made 
to determine how the individual domains of nsP2 (in the context of a multi-
domain protein arrangement) contribute towards the RNA-associated function-
alities of nsP2. The information gathered in such studies can be used towards 
the ultimate objective of proposing and standardizing a biochemical platform 
that would be essential for the screening of small molecule inhibitors capable of 
constraining CHIKV infection. In addition, the biochemical expertise developed 
during this study has been further used to develop alphavirus research tools 
such as antibodies, which could enhance our understanding of virus replication 
and virus-host interactions. These antibodies were not only confined to our lab 
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in Tartu, Estonia but were also used for global collaborative studies; by our best 
estimation, these antibodies represent the most efficient (and in some cases 
unique) tools for the detection of CHIKV proteins. As of March 2015, over 20 
laboratories on all continents (with the obvious exception of Antarctic) have 
requested and obtained these tools. Accordingly, these antibodies have been 
used for localizing alphaviral individual ns proteins inside the host cell, to de-
termine their cellular interacting partners, to analyze the dynamics of viral pro-
tein synthesis, to study the effect of antiviral compounds on viral replication etc. 
Similarly, expression constructs created during these studies are in use by at 
least ten different research teams. This highlights what is the last, but not the 
least, aim of these studies: to contribute to international collaboration and facil-
itate studies of important emerging pathogen.  
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3. REVIEW OF LITERATURE 
3.1. Alphavirus 
3.1.1. An overview of Alphaviruses 
Alphavirus like CHIKV belongs to the family Togaviridae. CHIKV was first 
reported during the 1952-53 epidemic in Makonde plateau in Tanzania, where it 
was isolated from the serum of a febrile patient (16). The name “Chikungunya” 
was derived from a word spoken by a population in the Mozambique region that 
means “bends up,” referring to the arthritic symptoms frequently caused by this 
virus (17). Recently, in 2005, CHIKV, which was known for its wide-spread 
geographical spectrum, re-emerged in East Africa and was transmitted to La 
Reunion Island located in the Indian Ocean, where it was reported to cause over 
300,000 cases. Subsequently, the virus was transmitted to India with an estima-
tion of six million infected cases, while European countries such as Italy and 
France as well as commonwealth countries such as Australia and also regions of 
southeast Asia were severely affected by this virus (18–27). The overlap be-
tween symptoms of CHIKV infection, which is characterized by high fever, 
head ache, nausea/vomiting, persistent myalgia/arthralgia and maculo papular 
rash, and those of DENV often leads to mis-attribution of the causative agent, 
instigating a severe socio-economic burden (28, 29). As DENV is more com-
mon than CHIKV, the number of actual CHIKV cases may be severely under-
estimated. The virus is also a great traveler: in November 2013 it emerged in the 
Caribbean islands and has by now (as of March 2015) affected more than 30 
countries in the region (including the Americas), with more than 1,300,000 
confirmed and suspected cases (http://www.paho.org). Currently, there are no 
therapeutics available against this virus, which demonstrates that we still lack 
an essential understanding of the mechanism employed by this virus to cause 
disease (20, 30). A recent review summarizes it all to a very simple expression: 
“CHIKV no longer simply threatens; it has arrived as a significant, global 
pathogen” (Fig. 2) (31). 
Based on serological cross-reactivity, the genus Alphavirus contains seven 
groups of viruses (called serogroups). Out of these, the VEEV, SFV and SINV 
groups are most prominent and accordingly are the best-studied. CHIKV be-
longs to the SFV serogroup of alphaviruses, which also comprises ONNV (the 
closest relative of CHIKV) and RRV (which has been well studied by different 
research groups as it is endemic and causes regular outbreaks in Australia and 
Oceania) (25). There are also members of the serogroup that have received little 
if any attention. Before 2004, CHIKV used to be one of these; however, this has 
been considerably improved. Despite efforts in the last 10 years to study 
CHIKV, still it remains relatively inadequately investigated, and many aspects 
of the molecular biology of this highly infective virus (such as the basis of 
chronic infection) are still completely enigmatic.   
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CHIKV is an arbovirus that is transmitted by the Aedes species of mosquitos, 
primarily by A. aegypti (more common in urban areas) and A. albopictus (more 
common in rural areas) (32). A. albopictus has, however, expanded its distribu-
tion and is currently present in metropolitan areas of Europe and the United 
States of America (17). It has been suggested that CHIKV had been maintained 
in a sylvatic cycle between wild primates and Aedes mosquito species in Africa, 
from where it spread to Asia (33). Whatever may be the cause, CHIKV is capa-
ble of establishing an urban cycle (human-mosquito-human) of transmission. 
Due to this ability, it has (since its discovery) caused more than ten million 
patient cases worldwide.   
 
 
 
Figure 2. Global distribution of CHIKV as of March 10, 2015; 
www.cdc.gov/chikungunya/geo/index.html 
 
 
CHIKV clearly originates from Africa. It has three different genotypes. Cur-
rently, most of the available data concerning the functions of the ns proteins 
originate from studies of proteins encoded by viruses belonging to the 
East/Central/South African (ECSA) genotype (typically from the Indian Ocean 
outbreak of 2005-2007). Two other genotypes of CHIKV, West African (WA) 
and Asian, have been studied to much lesser extent. It should be noted that the 
ns polyproteins encoded by viruses belonging to different genotypes demon-
strate 95% (WA compared to the other two genotypes) to 97% (ECSA com-
pared to the Asian genotype) identity. While the basic functions of ns proteins 
from viruses belonging to different genotypes are likely similar (possibly iden-
tical), a 3-5% difference in the aa sequence certainly suggests the possibility 
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that some of the non-enzymatic functions of nsPs encoded by different CHIKV 
genotypes may be substantially different.   
 
 
3.1.2. Virion 
Like other members of the genus Alphavirus, CHIKV is relatively small (~70 
nm), spherical, and produces enveloped virions (25, 34–37). The structure of the 
whole CHIKV virion has been studied by electron microscopy, while the indi-
vidual structural proteins have been investigated using X-ray crystallography 
methods. Such studies have revealed important insights into the overall organi-
zation of the whole virion as well as details about the structures of its surface 
proteins (38, 39). The cryo-electron microscopic structure of the CHIKV virion-
like particle (VLP) reveals that its overall structural organization is quite similar 
to virions of other alphaviruses (Fig. 3) (40, 41). The alphavirus virion has a 
molecular mass of approximately 5.2 x 106 Da and carries a protein-NA com-
plex called the “nucleocapsid” which is a firm assembly of a positive strand 
viral genomic RNA with an approximate size of 11.5 kb and 240 copies of cap-
sid protein arranged in icosahedral symmetry with a diameter of ~40 nm and 
triangulation number of four (T=4) geometry (25, 42, 43). The 110 N-terminus 
aa of the capsid protein, which is assumed to lack defined structure, is positively 
charged, corroborating its interaction with viral genomic RNA (44). The nucle-
ocapsid is further enclosed by a close-fitting, host-derived lipid bilayer that is 
also covered by an arrangement of almost continuous layer of envelope glyco-
proteins such as E1 and E2 and an extrinsic membrane protein, E3, in an icosa-
hedral lattice with T=4. A small amount of the membrane protein 6K is also 
reported to be unstoichiometrically associated with the viral particle (42, 45–
47). The glycoproteins E1 and E2 together form 240 copies of rigid heterodi-
mers and are arranged as 80 spikes protruding out from the lipid membrane of 
the viral envelope (Fig. 3A) (41, 48, 49). These spikes are representative 
arrangements of trimers of heterodimers (80 x [3 x E1-E2]) in the case of 
CHIKV (Fig. 3A) or trimers of heterotrimers (80 X [3 X E1-E2-E3]) as reported 
for SFV and VEEV (41, 50). These trimeric spikes constitute three distinct 
parts: first, a hollow, three-lobed extended projection of a 4.5 nm ectodomain 
from the surface for optimal interaction; second, a thin plate called a 'skirt' 
which covers the lipid bilayer; and finally, the transmembrane helix of E1 and 
E2, which both efficiently transverse the lipid bilayer in a pair-wise manner to 
establish direct physical contact with one monomer of capsid protein (44, 50, 
51). The envelope glycoprotein E2 and capsid protein are involved in an 
interaction that has been proposed to be critical for alphavirus budding (52). 
The lipid bilayer membrane between the nucleocapsid and the envelope layer is 
also associated with cholesterol and sphingolipids, which govern both virus 
fusion and budding (Fig. 3B) (53–56).  
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Figure 3. Structure of a CHIKV-like particle (CHIK-VLP) showing the arrangement of 
surface proteins, adapted from (41). A) Cryo-electron microscopy analysis of CHIK-
VLP ectodomain spikes, each of which is a trimer of heterodimers (E1-E2). The VLP is 
approximately 70 nm in diameter. B) Transectional arrangements of different layers 
towards the interior, starting from the envelope proteins, lipid membranes, capsids and 
RNA, which are color coded. Please refer to the text for more detail. 
 
 
3.1.3. Genome organization  
Alphaviruses have positive strand RNA genomes approximately 11,600 nt in 
length (SINV: 11,700, SFV: 11,500 and CHIKV: 11,800-12,000) that are 
capped and polyadenylated at the 5' and 3' ends, respectively (Fig. 4) (57, 58). 
After introduction into the host cell, this genome directly acts as an mRNA that 
is immediately ready to be translated. The genome contains two ORFs. The first 
ORF, corresponding to nearly two thirds of the genome, codes for the ns poly-
protein or polyproteins (nsP1234 or nsP123 and nsP1234) depending on the 
presence or absence of a termination codon near the end of the nsP3 coding 
region (Fig. 4) (59). These polyproteins are precursors of ns proteins that form 
the virus-encoded part of the replicase and are fundamental towards viral RNA 
replication. The third of the genome at the 3' end contains a smaller ORF that 
codes for the viral structural proteins: C, E1 and E2 and also certain small pro-
teins such as E3, 6K or TF, which broadly contribute to the encapsidation of the 
viral genome. Like ns proteins, the structural proteins are also produced in the 
form of polyprotein precursors.  
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Figure 4. Alphavirus genome structure, showing the conserved sequence element 
(CSE) (25, 60). The translational enhancer sequence (TES) is characteristic for some 
viruses (SFV) but absent from the genomes of other (CHIKV) alphaviruses. Note also 
the genomic RNA stretch (42S RNA) and the sg RNA stretch (26S RNA) (25); refer to 
text for more details. 
 
 
The ns polyprotein is directly translated from the viral genome, which is also 
designated 42S RNA in case of SFV or 49S in case of SINV. In contrast, the 
structural portion is translated from a sg RNA which is often designated 26S 
RNA (Fig. 4). Both the genomic and sg RNA have a 5' terminal cap and 3' poly-
adenylation similar to eukaryotic mRNA (25). During RNA replication a nega-
tive polarity RNA complement that carries an unpaired G residue at the 3' end 
but lacks poly(U), which is complementary to the poly(A) tail of genomic RNA, 
is generated based on the template of the positive polarity genomic RNA. Neg-
ative strand RNA (most likely in duplex with genomic RNA) acts as a template 
for subsequent transcription of both genomic and sg RNA. The negative strand 
RNA lacks a cap structure (61, 62). The viral RNA genome also contains three 
NTRs that are present at both ends of the genome and at the intersection of ns 
and the structural ORF. These regions are essential for the controlled synthesis 
of replicative RNA intermediates and also for immune evasion (Fig. 4) (63). 
The three NTR regions include three CSEs: one towards the 5' end, one near the 
3' end and one present at the intersection of ns and the structural ORF (Fig. 4). 
The final CSE (CSE2) is located in the coding region of the ns polyprotein. 
CSE1 towards the 5' terminus has demonstrated considerable sequence variabil-
ity however, the SL1 comprising approximately the first 40 nt of this region are 
structurally conserved among alphaviruses. CSE2, which comprises 51 con-
served nt starting approximately 150 nt from the 5' terminus, is located in the 
nsP1 coding region and forms two stable hairpins (SL 3 and 4) (Fig. 4) (64). 
The complements of CSE 1 and 2 at the 3' end of the negative strand were 
shown to affect both negative and positive strand RNA synthesis (60, 65). As 
indicated above, the replication intermediate, which represents dsRNA com-
prising both the positive and negative RNA strands, acts as a template for suc-
cessive genomic and sg RNA synthesis (58, 66, 67). For genomic RNA synthe-
sis, the complement of SL1 in CSE1 at the 3' end of the negative strand RNA 
acts as a core promoter (68), while adjacent elements of this region improve the 
efficacy of synthesis of genomic RNA. CSE2, including SL 3 and 4, is im-
portant for both positive and negative RNA synthesis (Fig. 4) in a host-specific 
manner: it is indispensable for genomic RNA synthesis in insect cells but not in 
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vertebrate cells while deletion of SL2 leads to enhancement of RNA replication 
in vertebrate cells (60, 64). This leads to the hypothesis that these elements bind 
to cell-type specific interacting partners (69). CSE3, which overlaps with the 
region encoding for the C-terminus of nsP4 and extends up to the non-coding 
region upstream of the structural region, was identified as a sg promoter. 
Indeed, sequence complementary to this sequence on the negative strand RNA 
acts as a promoter for the synthesis of sg RNA (Fig. 4). The minimal length of 
this region capable of supporting sg RNA synthesis could be as short as 24 nt (-
19/transcription start site/+5), while for efficient sg RNA synthesis this region 
should be long, up to 112 nt (-98/transcription start site/+14) in length (70–72). 
To note, these data are implied for SINV, although the lengths of the minimal 
(and/or maximal) sg promoters of other alphaviruses could be different. CSE4, 
comprising 19 nt immediately preceding the poly(A) tail of the genomic RNA, 
acts as a part of the promoter required for the synthesis of negative strand RNA 
(Fig. 4) (60, 73, 74). Mutational studies in these regions have shown that initia-
tion of negative strand RNA occurs at the last nucleotide before the poly(A) tail. 
The start site of the negative strand could be shifted using certain mutations; 
however, this type of non-wt initiation compromises the productivity of elonga-
tion (75).  
In a late stage of infection, the 5' portion of the capsid gene of SINV, en-
coding for the first 34 aa of the capsid protein, acts as translational enhancer and 
facilitates efficient translation of structural proteins in infected cells (76, 77). 
This region, located close to the 5' region of sg RNA, also carries several stable 
SL structures that assist in cap-independent translation, compensating for the 
viral-induced shutdown of host cell translation (76–79). This function, however, 
is not conserved. Capsid enhancer is found in the corresponding region of the 
SFV genome but lacks in the genomes of other alphaviruses, including VEEV 
and importantly also for CHIKV. The region encoding for the 6K protein has 
been shown to carry a -1 ribosomal frame shift signal, recognition of which 
gives rise to a small structural protein called the TF (80). The alphaviral ge-
nome also carries a packaging signal sequence, but the position of this signal 
and its sequence vary considerably between different alphavirus species. In the 
case of SINV, nt 945-1076 of the nsP1 region are important for packaging of 
the genome. In the case of SFV, the packaging signal is located in the region 
between nt 2767-2990 (nsP2 encoding region), and for RRV several probable 
packaging signals have been mapped (81, 82). 
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3.1.4. Alphavirus replication cycle  
 
Figure 5. Replication cycle of alphaviruses: from virus entry to budding and escape. 
Note that for the sake of simplicity, all cell organelles have not been shown (83, 84).  
 
 
3.1.4.1. Alphavirus entry 
Alphavirus entry is primarily initiated by the binding of E2 glycoprotein with 
one or multiple cell surface receptors (Fig. 5) (85, 86). However, as alpha-
viruses target very diverse cell types, from vertebrates to invertebrates, which 
are very different in their surface architecture, an omnipresent receptor is highly 
unlikely to facilitate the binding of virions to the cell surface. Thus, use of al-
tered or multiple receptors on different cell types is more likely to contribute to 
this event. It has been demonstrated that SINV employs natural resistance-asso-
ciated macrophage protein (NRAMP), a divalent metal ion transporter that ena-
bles its entry into both mammalian and insect cells. RRV, which belongs to the 
SFV serological complex, does not exploit the same receptor. Thus, generaliza-
tion of the attachment process is difficult (87). It has also been shown that SINV 
uses the laminin receptor to assist its entry into mammalian and insect cells, as 
an antibody directed towards the C-terminal domain of laminin partially 
blocked viral entry into mosquito cells (88). In a another study, SEC61A and 
valosin-containing proteins were reported to regulate SINV entry into insects 
and mammalian cells (89). The entry of RRV into mosquito cells has also been 
reported to be supported by the binding of E2 glycoprotein to laminin (90). DC-
SIGN and L-SIGN, proteins belonging to C-type lectin family, which preferen-
tially binds to mannose-rich glycoproteins, are also broadly proposed to act as 
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receptors for alphavirus entry (91). In addition, heparan sulfate has been demon-
strated to be the binding receptor for SINV entry (92, 93). Using anti-idiotypic 
rabbit polyclonal sera, it has also been shown that on chicken cells an anony-
mous 63 kDa protein could act as a receptor for SINV entry (94), while in the 
case of SFV, class I major histocompatibility antigens were found to mediate 
infection of human and murine cells (95). 
Receptor-mediated endocytosis has been extensively investigated and is 
supported by solid data (44, 96–99). Recently, it was reported from genome-
wide RNAi screening that a homologue of Fuzzy, a protein involved in planar 
cell polarity and cilia biogenesis, supports clathrin-dependent alphavirus inter-
nalization (100). Thus, in general, cumulative evidence supports the receptor 
mediated endocytosis mode of alphavirus entry. Still, there have been reports of 
other modes of initiation for virus infection in which the virus comes in direct 
contact with the plasma membrane, bypassing the stage of classical endocytosis. 
According to this alternate hypothesis, a pore complex derived from viral and 
host proteins is formed, which connects the interior of the virus to the suscepti-
ble cell cytoplasm (101). 
According to a more widely accepted model, the binding of virions to cell 
surface receptors is followed by swallowing the particle, which is later found in 
endocytic vesicles. Acidification of endosomes leads to the fusion of viral and 
endocytic membranes, and the nucleocapsid is released into the cytoplasm (Fig. 
5) (102). This fusion is also reported to be driven by the presence of cholesterol 
and sphingolipid in the target membrane (53, 55). Few detailed studies suggest 
that the low pH of the endocytic vesicle destabilizes the E1-E2 heterodimer to 
expose the fusion loop of E1, which otherwise (at neutral pH) would have re-
mained hidden within the E1-E2 complex (103, 104). The fusion loop is in-
serted into the target membrane, where it trimerizes. This is associated with 
melting of the viral and endocytic membranes and leads to the creation of a pore 
through which the nucleocapsid exits into the cytoplasm. In the case of several 
alphaviruses, including SINV, SFV and CHIKV (but not in the case of structur-
ally related DENV, a member of the Flaviviridae family), it has been further 
described that a tetraspanin membrane protein, TSPAN9, has a critical role in 
this type of low pH-activated membrane fusion (100, 105–108). The changes in 
the viral envelope architecture are followed by structural changes in the nucle-
ocapsid, which is the viral RNA-protein complex (102, 109, 110). Once the 
nucleocapsid is in cytoplasm their disassembly happens very quickly within 1 to 
2 minutes by the recruitment of ribosomes which interact with the capsid pro-
teins permitting the release of viral genomic RNA which becomes available for 
translation (96, 106).  
 
 
3.1.4.2. Overview of RNA replication 
The alphaviral genome directly serves as mRNA for the production of viral ns 
polyprotein cleavage products, which form the virus-encoded portion of the 
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replication complex. The regulated synthesis of different types of viral RNAs 
(negative strand, new genomes and sg RNAs) is associated with the meticulous 
processing of the viral ns polyprotein (111). In alphaviruses such as SINV, 
VEEV and some strains of SFV, an opal termination codon (UGA) is present 
towards the end of the nsP3 coding region such that in these cases the viral 
genome serves as a template for the synthesis of a dominant nsP123 and a small 
proportion of full length nsP1234 polyproteins. The latter is possible due to the 
ribosomal read-through that occurs in 10-20% of cases (59, 112). In a complete 
nsP1234, the nsP3 portion also carries an additional 6 aa in its C-terminus. 
These originate from a region located downstream of the stop codon and forms 
part of the cleavage site between nsP3 and nsP4. Thus, in cells infected with 
these viruses, two forms of alphaviral nsP3 exist (25, 113, 114). It has also been 
shown that the presence of an opal termination codon between nsP3 and nsP4 
enhances ONNV virus fitness during mosquito infectivity and could also alter 
virulence (115, 116). Conversely, a number of alphaviruses only produce 
nsP1234 due to the absence of an in-frame opal termination codon. Examples 
include several SFV isolates such as SFV4 and SFV L10 and CHIKV isolates 
such as LR2006OPY1 (cloned variant, clinical isolate has terminator), SGP011 
and IND91. It is very likely that natural isolates of alphaviruses contain ge-
nomes with and without a terminator. 
The peptidase activity residing in the C-terminal portion of nsP2 is solely re-
sponsible for the cleavage of nsP1234 to liberate nsP1, nsP2, nsP3 and nsP4 in a 
precisely regulated manner that is tightly connected to the synthesis of viral 
related RNA of different polarities (Fig. 5) (66). In the first 6 hours p.i., the 
viral replicase protein nsP4, which possesses RdRp enzymatic activity, and 
nsP123 (still uncleaved) direct the synthesis of the genome-length negative 
strand RNA, which later acts as a template for the synthesis of genomic and sg 
RNA of a positive polarity (117). It is likely that each positive strand can be 
used only for the synthesis of one negative strand, which forms dsRNA with its 
template. The replicase proteins for negative RNA synthesis are therefore con-
stantly reintroduced from 4–6 hour p.i., after which no new negative strand 
synthesis complexes are made (118, 119). Thus, maximal amounts of negative 
strand RNA are reached approximately 6 hours p.i., and these amounts remain 
at the same levels thereafter. This could, however, be altered by certain muta-
tions in nsP2: for corresponding viruses, incessant minus strand synthesis is 
observed beyond the mentioned time frame (120–122). In contrast to minus 
strand synthesis, positive strand synthesis is stable and continues for several 
hours, even tolerating the addition of protein synthesis inhibitors (57). Due to 
the presence of a relatively stronger promoter for sg RNA synthesis (compared 
with promoters used for genomic RNA synthesis), sg RNA synthesis proceeds 
more proficiently than genomic RNA in later stages of infection (60). Quantita-
tion of minus strand RNA copies per BHK-21 cell gave a number of approxi-
mately 27,000 copies per cell; in chicken embryo fibroblasts, this amount was 
considerably less (likely due to the smaller sizes of these cells). In vertebrate 
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cells, the positive strands are clearly more abundant with copy numbers of 
200,000 and above and genomic to sg RNA ratios of 1:2 to 1:5 (120, 123, 124). 
 
 
3.1.4.3. Replication machinery 
Although the alphaviral genome codes for approximately 10 different proteins, 
only 4 ns proteins and their precursors are absolutely required for RNA replica-
tion. The proteins contribute to the formation of highly organized and fine-
tuned replication complexes inside the host cell, the modulation of which is 
primarily governed by polyprotein processing by a peptidase residing in the 
nsP2 portion of the polyprotein (Fig. 5) (125–128). In infected cells, along with 
other host factors, the viral portion of the replicase complex involves different 
cleavage products of nsP1234. As infection proceeds, their processing as well 
conformational alterations lead to the formation of early, intermediate and late 
replication complexes; this determines which polarity of viral RNA will be 
synthesized: 
- At an early stage of infection, during translation, nsP4 is cis cleaved out 
from nsP1234 and together with the nsP123 polyprotein; it functions in the 
production of genome-length negative polarity RNA. Thus, nsP4 + nsP123 
are referred to as the early replicase complex (or negative strand replicase) 
(Fig. 6). 
- Another cis cleavage, which occurs between the nsP1 and nsP2 regions of 
nsP123, leads to the formation of a complex consisting of nsP1, nsP23 and 
nsP4. This entity is known as the intermediate replication complex and is ca-
pable of synthesizing viral RNAs of both polarities. The complex is very 
short lived, at least in the case of SFV and SINV. 
- The final cleavage, which occurs in trans, functions to separate nsP2 and 
nsP3 and leads to the formation of a stable complex consisting of individual 
ns proteins. This is termed as the late replicase complex or positive strand 
replicase complex, as it produces both genomic and sg RNA of a positive 
polarity, a process that lasts until the death of the infected cells (Fig. 5 and 6) 
(117, 126, 129–131). The formation of the late replication complex as a re-
sult of the trans cleavage of nsP2 and nsP3 is the final commitment of the 
replicase to exclusively synthesize positive polarity genomic and sg RNA 
from dsRNA intermediates, which results in a point of no return according to 
current dogma (Fig. 6) (122, 130–134).  
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Figure 6. Sequential polyprotein processing in alphavirus. Note how the processing 
supports the replication of RNA with different polarities (positive and negative). The 
proteases responsible for the cleavage-processing of ns and structural proteins have also 
been shown (25) and http://viralzone.expasy.org/all_by_protein/3.html. 
 
 
At a later stage of infection (6 h p.i. and later) when the concentration of indi-
vidual nsP2 builds up in the cytoplasm, the newly synthesized nsP1234 is pro-
cessed in a different order: cleavage of the 2/3 site occurs first, leading to the 
formation of the nsP12 and nsP34 polyproteins. The cleavage occurs co-trans-
lationally or just after the synthesis of the new nsP1234 (135). These molecules 
or their cleavage products cannot form replicase complexes and are used to 
produce individual nsPs, which are not included in replicase complexes. None-
theless, they are important for virus infection and the functionality of each is 
described in later sections. 
 
 
3.1.4.4. Site of RNA replication  
The replication of positive strand RNA virus is a highly regulated process. The 
replication machinery is not dispersed throughout the host cell; instead it is 
concentrated and located in compartments, often co-opting the membrane-
bound infrastructure in such a way that the confined settings not only provide 
the required microenvironment for the process, and only the molecules related 
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to or supporting viral RNA replication can be transported in and out, but also 
optimal usage of the available resources is ensured.   
In infected cells, alphaviral RNA replication occurs inside a compartment 
(sometimes called the “virus replication organelle”) derived from modified 
endosome and lysosome called “CPV I or CPV” with a size ranging from 600 to 
2,000 nm (136). Inside these CPVs, multiple small, regular, light bulb-shaped 
membrane invaginations called “spherules2 (with a diameter of approximately 
50 nm; visible by electron microscopy) are located. These “spherules” are true 
replication complexes and contain all alphavirus replication machinery. For-
mation of spherules is coupled with the synthesis of negative strand RNA; no 
spherule is formed without RNA replication (137, 138). Electron microscopy 
images reveal that the size of a spherule is determined by the length of the RNA 
packed into these structures (139–143). It has also been found that all four repli-
case proteins are associated with the spherule, and anchorage of the replicase 
complex to the spherule membrane is governed by nsP1. For material exchange 
(transport of nucleotides and RNA molecules), the spherules are connected to 
the cytoplasm by a neck-like structure with an inner diameter of 8 nm (139, 
142, 144, 145).  
Live cell imaging techniques along with electron microscopy suggest that 
the spherules are first formed and accumulate along the plasma membrane. 
Their formation is followed by internalization via an endocytosis-like process 
that is driven by the phosphatidylinositol 3-kinase and actin-myosin network. 
The process occurs efficiently in the case of SFV, and vesicles, containing 
spherules, are later fused to acidic endosomes and displaced in multiple direc-
tions using microtubules, leading to the formation of CPVs, which localize 
around the nucleus (146). CPVs carry different late endosomal and lysosomal 
marker proteins, while the ns proteins are identified on the cytoplasmic face of 
the limiting membrane of the CPV (139, 142). These processes are tightly rein-
forced by ns proteins, especially nsP1 and nsP3. NsP1 anchors to the plasma 
membrane, while nsP3 is essentially needed for transportation to the lysosome 
(147–149). The internalization of spherules is not an absolute requirement, and 
inhibitors of the process do not diminish viral RNA replication. Furthermore, 
for several alphaviruses, including CHIKV, the internalization of replicase 
complexes is rather inefficient. In cells infected with CHIKV, replicase com-
plexes stay near the plasma membrane, and prominent CPVs are not formed. 
The molecular bases of these different behaviors are unknown. 
 
 
3.1.5. Structural proteins and their processing 
Alphavirus sg RNA acts as an mRNA for the translation of the structural pro-
teins. These are produced as polyprotein precursors, and their processing and 
post-translational modifications are important and demand specific elaboration 
(25). The order of mature proteins in the alphavirus structural polyprotein is C-
E3-E2-6K-E1. The E3-E2 precursor is commonly called p62 based on its 
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molecular mass (Fig. 6) and has the longest half-life among the precursors of 
the structural proteins (125, 127, 150, 151). For wt SFV, a vertebrate cell-spe-
cific translational enhancer involving a region encoding the first 102 aa of the 
capsid protein has also been reported in sg RNA (77, 152). The capsid protein is 
autocatalytically cis cleaved out from the structural polyprotein. This cleavage 
liberates the N-terminus of p62, which carries the ER membrane translocation 
signal. The translocation is essential as the membrane-bound portion of the 
polyprotein undergoes further extensive modifications and is cleaved by cellular 
proteases to individualize the p62, 6K and E1 proteins followed by pal-
mitoylation and glycosylation (Fig. 6) (151, 153, 154). As alphaviruses shuttle 
between vertebrate and invertebrate hosts, it is tempting to postulate that post-
translational modification could be different based on the host species. Along 
this line of thought, it has been shown recently in case of SFV by ion mobility 
mass-spec and collision-induced dissociation analysis that E1 and E2 could be 
glycosylated to a different degree. The composition of glycans associated with 
these proteins varies according to the structure of the individual surface proteins 
and host-specific enzymes (155). Binding to the membrane is essential for 
proper folding, modification and processing of these proteins. 
 
 
 
Figure 7. Alphavirus structural protein arrangement on the membrane of the endoplas-
mic reticulum showing capsid, E1, E2, E3 and the protease responsible for the cleavage 
of individual protein (156). 
 
 
P62 and E1 form a heterodimer in the ER that is transported to the Golgi; during 
this time, p62 is processed by furin to liberate E3 and E2 (Fig. 6 and 7). This 
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leads to E2-E1 heterodimer formation, and these complexes are transferred to 
the plasma membrane where they participate in virion formation. In the case of 
SFV and VEEV, E3 is also incorporated into the virion; however, in the case of 
SINV (and CHIKV), E3 is absent or may not contribute during this process. The 
6K protein is present in virions in very small amounts and may influence the 
interactions between E2 and E1 (25, 41, 44, 50, 84, 84, 157). If a ribosomal 
frame shift occurs during 6K synthesis, a TF protein is synthesized. The exist-
ence of this protein has been confirmed using mass spectrometry; however, its 
functions are largely unknown except that it is somehow important for alpha-
virus virion assembly (80, 158).  
 
 
3.1.6. Individual structural proteins 
 
Figure 8. CHIKV genomic RNA with 5' cap, 3' poly(A) and NTR regions at both ends 
of the genome. Sizes of mature ns and structural proteins and start positions of corre-
sponding coding regions are shown. Note that sg RNA codes for the structural proteins 
((35, 159, 160) and UniProt entry Q8JUX5). 
 
 
3.1.6.1. Capsid protein 
Capsid protein (33 kDa) is an enzymatically active protein. The C-terminal 
domain of capsid protein exhibits sequence conservation towards a serine pro-
tease (161, 162). So this protein has protease activity that is used for cis cleav-
age at its C-terminus (Fig. 8) (163). After this processing event, protease activ-
ity of the capsid protein is inhibited as the catalytic site is occluded due to a 
conformational change (25). The N-terminal variable region comprising 96 aa 
(SINV), which is rich in positively charged aa residues, has no defined 3D 
structure and binds viral RNA. This interaction is crucial for the formation of 
nucleocapsid. The C-terminal conserved portion of this protein binds to the E2 
glycoprotein (25).  
Capsid protein also has functions that are not related to virion formation. 
This is especially evident for New World alphaviruses. It has been shown that 
one of the N-terminal sub-domains of VEEV capsid protein is not necessary for 
viral particle assembly; instead, this region regulates viral RNA encapsidation. 
Mutation in the capsid protein has been reported to be compensated for by mu-
tation in nsP2 (164) and vice versa (unpublished data from our lab), indicating 
some involvement in RNA synthesis and/or selection. For New World 
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alphaviruses, the capsid protein is the main determinant for the shutdown of 
host cell transcription and antiviral responses. The protein has both nuclear 
export and nuclear import signals and, by interacting with corresponding cellu-
lar proteins, it blocks nucleo-cytoplasmic transport (165–167). In the case of 
CHIKV, it has also been demonstrated that the capsid protein interacts with 
karyopherin α to translocate into the nucleus, whereas interaction with the ex-
port receptor CRM1 results in displacement of this viral protein from the nu-
cleus (168). Thus, trafficking in and out of nucleus is also characteristic of cap-
sid proteins of Old World alphaviruses; however, the biological significance of 
this process is not yet known. 
 
 
3.1.6.2. Envelope proteins 3 and 2 
E3 (11 kDa) is a glycoprotein resulting from the cleavage of p62; this cleavage 
is performed by furin in the trans-Golgi compartment (Fig. 6, 7 and 8). E3 fa-
cilitates proper folding of p62; p62 itself interacts with E1 to influence spike 
function. E3 is also believed to influence E2-E1 heterodimeric complex for-
mation and allows its transportation to the site of budding via acidic compart-
ments of the cell. E3 interacts with E2 by Tyr47, which protects E1 from low 
pH (169). The cleavage of E3 from the spike complex activates the fusion abil-
ity of the E1 protein. Thus, E3 is important for viral particle assembly and indi-
rectly also for viral entry (44, 170, 171).  
The 51 kDa E2 protein, another product of the furin cleavage of p62, is a 
transmembrane protein. It is glycosylated and palmitoylated; both of these 
modifications are essential for virion budding (Fig. 6, 7 and 8) (172, 173). The 
260 aa from the N-terminus of E2 form an ectodomain, while the next 100 aa 
form a stem-like region and the remaining 30 aa form a transmembrane region 
(171, 174). The C-terminus of the E2 protein also interacts with the nucleocap-
sid. As mentioned above, E2 eventually forms E1-E2 heteroduplex complexes. 
In these complexes, E2 is responsible for binding to the cell surface receptor 
and subsequent endocytosis (25, 44). It has also been described that an anti-
idiotypic neutralizing antibody binds to an epitope in the E2 protein. A mono-
clonal antibody against this glycoprotein is reported to protect mice against 
CHIKV disease; a number of studies have also shown that this structural protein 
is a major viral antigen and thus represents a possible therapeutic target (94, 
175–177). Recently, it has been observed that E2-64 and E2-208 mutations 
lower the dissemination of the E1-226V CHIKV variant in Aedes aegypti but 
not in Aedes albopictus mosquitos. This is apparently due to an aberrant inter-
action between CHIKV and mutant E2:E1-226V spikes and cellular receptor in 
the A. aegypti midgut (178, 179).  
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3.1.6.3. 6K and Transframe proteins  
6K is a relatively small 60 aa long structural protein. Translation of this coding 
frame can also lead to formation of another protein with a C-terminal extension 
known as TF. TF is an 8 kDa protein, and its synthesis requires a ribosomal 
frameshift. It has been shown that this frameshift occurs with an approximate 
frequency of 10-18% (Fig. 8). In the SFV virion, the TF protein is present to a 
considerable extent. In contrast, 6K is present in much smaller amounts. 6K 
facilitates virion formation but is not absolutely required (which is true for TF 
as well). These two proteins both undergo acylation; the TF protein also under-
goes palmitoylation, whereas 6K undergoes glycosylation (46, 80, 157). 
Manipulation or mutations in the 6K region affect infectious virus production; 
however, even complete deletion of this region is not fatal. It has been shown 
that mutations and deletions in 6K can be compensated for by mutation in E2, 
providing evidence that these two proteins interact (46, 150, 180, 181). The 6K 
protein is also involved in the modification of membranes in cells of mamma-
lian origin, and it likely represents a cation-specific viroporin (182–186). 
 
 
3.1.6.4. Envelope protein 1  
E1 is a 50 kDa transmembrane glycoprotein that is also modified by the addi-
tion of fatty acids and resembles flavivirus E protein (172, 187). In virions, it 
forms a continuous icosahedral shell covering the lipid bilayer. E1 is pal-
mitoylated and this modification contributes to the stability of budding virions 
(Fig. 8) (188). The E1 protein has been reported to be responsible for mediating 
viral membrane fusion with the host endosomal membrane during virus entry 
(189). Indeed, at low pH the E1 becomes capable of fusion. A specific histidine 
residue at the third position of the E1 protein assists in low pH-dependent re-
folding during the course of fusion (44, 190).  
The E1 protein is also reported to play a crucial role in viral adaptation and 
evolution. It has been clearly shown that it was the E1-A226V mutation that 
resulted in added fitness of CHIKV for the A. albopictus mosquito vector. This 
mutation greatly facilitated the spread of the virus via A. albopictus mosquitos 
and was clearly among the major factors contributing to the 2005-2006 Indian 
Ocean epidemics (23, 179, 191). In a study carried out to identify post-
2005/2006 epidemic mutations, two mutations, V80I and A129V, were mapped 
to the E1 region when mosquitos were infected with the E1-A226V CHIKV 
strain (192). This mutation also induces the virus to acquire multiple second-site 
mutations such as E2-L210Q, which is proposed to contribute towards “super 
adaptive CHIKV” with enhanced transmission efficiency (193). Interestingly, 
however, the E1-A226V mutation does not facilitate transmission of CHIKV of 
Asian genotypes. This is due to the T98 residue in the E1 protein of this CHIKV 
genotype (194) 
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3.1.7. Nonstructural proteins 
As described earlier, the alphavirus genome encodes for four ns proteins. As 
these proteins along with other host factors form viral replicase complex and 
also have additional essential functions, they are immensely important for the 
viral replication inside the infected host cell. The ns proteins also interact with 
host factors; these interactions are important both for replicase function and for 
influencing cellular functions to support infection. In this line of thought, it is 
plausible to imagine that almost all the ns proteins individually or as a part of 
the replication complex multitask to a large extent. Clearly, these proteins are 
able to carry out versatile activities to complement the other ns proteins in this 
process; thus, detailed descriptions of the individual ns proteins follow.  
 
 
3.1.7.1. Nonstructural protein 1 
NsP1 (60 kDa; 535 aa in SFV and CHIKV) determines the localization of the 
replication complex inside infected cells because it has an inherent ability to 
bind to the plasma membrane. This is facilitated by the presence of a positively 
charged-hydrophobic peptide of 19 aa between residues 245 and 263 (in case of 
SFV, the sequence of the peptide is GSTLYTESRKLLRSWHLPS). This pep-
tide can form an amphipathic helix and is crucial for viral replication. Though 
the initial interaction with membrane occurs via the amphipathic helix, the final 
membrane anchoring of the protein is mediated by palmitoylation of cysteine 
residues between aa 418–420 (Fig. 9). The amphipathic-like helix is arranged in 
plasma membrane in such a way that the hydrophobic residues can interact with 
the lipid bilayer while the positively charged residues interact with the nega-
tively charged group of phospholipids. Comparable peptides can be found in 
many viruses related to alphavirus (144, 147–149, 195, 196). In the case of 
SFV, mutations in this conserved peptide not only affect the membrane binding 
properties of the protein but also hamper the enzymatic activities of nsP1 (see 
below). However, this is not universal as nsP1 of SINV, which is devoid of 
membrane binding, is still partly biochemically active. In the case of SFV, it 
was shown in a competition experiment that a putative membrane binding pep-
tide could compete with nsP1 to bind liposomes containing phosphatidylserine 
(147, 196, 197). The specific affinity of nsP1 for the negatively charged 
phospholipids and the lipid bilayer leads to the formation of tunnel-like projec-
tions of a nano-scale size that resemble filopodia-like structures via an unknown 
mechanism (195, 198). Palmitoylation is an important requirement for nsP1 to 
induce these types of structure (148, 195). These structures, which are common 
to many RNA viruses and retroviruses, have also been reported to be associated 
with membrane proteins such as ezrin and glycoprotein receptors such as CD44. 
However, it remains unknown to what extent these structures could be used by 
alphaviruses to spread infection from infected cells to adjacent cells (198–201). 
Additionally, it has been revealed that if nsP123 or nsP1234 are expressed as an 
37 
 
uncleavable polyprotein, the nsP1 portion of these molecules can still undergo 
palmitoylation and guide the polyprotein to cytoplasmic membranes (145). 
Mutations preventing the palmitoylation of nsP1 reduce virus infectivity. This 
effect is most likely not due to weaker membrane attachment but due to dis-
turbed interactions between nsP1 and nsP4. It has been found that multiple 
compensatory mutations can restore these interactions. Interestingly, these mu-
tations also restore the formation of filopodia-like structures, at least to some 
extent (202). The direct interaction between nsP1 and nsP4 has also been rein-
forced by studies involving co-immunoprecipitation techniques. One of these 
study reported that the N-terminus of nsP4 interacts with nsP1 during the initia-
tion of minus strand synthesis, while another study reported that modification of 
the N374 residue in nsP1 of SINV influences the ability of nsP4 to synthesize 
minus strands (203, 204). From these pieces of evidence, it could be broadly 
perceived that nsP1 plays a direct or an indirect role in the synthesis of negative 
strand RNA by interacting with nsP4.  
 
 
 
Figure 9. Schematic representation of alphaviral nonstructural protein 1. Regions cru-
cial for enzymatic (methyl- and guanylyl transferase) activity, the amphipathic helix and 
the palmitoylation region are shown. Amino acid residues are numbered based on nsP1 
of SFV (35, 149, 195). 
 
 
NsP1 also harbors enzymatic activities that are essential for cap synthesis. This 
is pivotal for making viral genomic and sg RNA essentially non-distinguishable 
from host mRNA (205) (Fig. 9). These actions of nsP1 contribute to the for-
mation of a cap-0 structure that supplements and complements the RdRp activ-
ity of nsP4, which synthesizes new RNA of a positive polarity and the RTPase 
activity of nsP2, respectively (206–208). Briefly, nsP4 synthesizes new positive 
strand RNA that carries three phosphates at its 5' end. Subsequently, the gamma 
phosphate is removed by the RTPase activity of nsP2 to give rise to an RNA 
molecule with two phosphates at the 5' end. Afterwards, a GTP molecule is 
methylated at the 7' position of the guanine (m7GTP) by the guanine-7-methyl-
transferase (MTase) activity of nsP1, which uses S-adenosyl-L-methionine 
(Ado-Met) as a methyl group donor. Later the guanylyltransferase (GTase) 
activity of nsP1 catalyzes the release of two terminal phosphates which allows 
the formation of methylated-GMP covalently bound to nsP1 (m7GMP-nsP1) 
transfer complex. Finally, the methylated GMP (m7GMP) is transferred to the 5' 
terminus of the RNA to conclude the formation of a 5'-5' covalent bond between 
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RNA di-phosphate and the methylated GMP moiety (205, 206, 209–211). 
Recently it has been reported that S-Adenosyl-L-homocysteine (Ado-Hcy), a 
byproduct of the preceding MTase reaction is essential for the following GTase 
reaction (211). Mutations changing key residues in the “MTase motif” (H39, 
R91, N94, and Y249 residues; numbered based on nsP1 of SINV) to alanine 
residues abolishes MTase activity and viral infectivity (212). As indicated 
above, MTase and GTase activities of nsP1 of SFV are dependent on the 
membrane binding of nsP1. Thus, washing out the phospholipid by detergent 
abolishes the enzymatic activity of nsP1, while supplementing these settings 
with phosphatidylserine restores the activity. In contrast, SINV nsP1 did not 
demonstrate such dependence; instead, a nonionic detergent abolished nsP1 
GTase activities without affecting the MTase activity (147, 197). 
 
 
3.1.7.2. Nonstructural protein 2 
NsP2 (90 kDa; 799 aa in SFV and 798 in CHIKV) is the largest multi-tasking 
and the most multifaceted protein among the ns proteins of alphaviruses. NsP2 
possesses four enzymatic functions: RTPase, NTPase, protease and helicase 
activities; additionally, a number of important non-enzymatic activities such as 
causing cytotoxic effects related to the shutdown of cellular transcription and 
translation machineries have been associated with this protein (Fig. 10). Thus, it 
is very plausible to anticipate that a number of extensive studies have been car-
ried out to characterize these features of nsP2 (166, 209, 210, 213–220). Bioin-
formatical analysis and structural data have assigned this protein five different 
domains: N-terminal domain (NTD) aa 1–167, 1st RecA-like domain aa 168–
311 (1A), 2nd RecA-like domain aa 312-470 (2A), protease domain aa 471–605 
and MTL domain aa 606-798 (aa residues numbered based on nsP2 of CHIKV; 
Fig. 10). The functional significance of these domains has been discussed in 
different contexts throughout this thesis. Furthermore, the subcellular localiza-
tion of nsP2 inside infected cells is also intriguing. In the case of SFV, 25% of 
nsP2 is associated with virus replicase organelles, another 25% is diffusely 
present throughout the cytoplasm and a large fraction of approximately 50% is 
present inside the nucleus, especially the nucleolus. These distributions are 
believed to assist in hijacking or manipulating host cell machineries to support 
viral RNA replication (142, 221).  
 
 
 
Figure 10. Schematic representation of the domain organization of nsP2 of CHIKV. 
The C-terminal region starting at 470 is historically considered to be a protease domain, 
while the N-terminal region is responsible for the NTPase and RTPase activity (210, 
215, 220, 222). Please follow the text for more details. 
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The N-terminal aa 1–470, in the case of nsP2 from SFV, and fragments span-
ning from aa 1–470 or aa 166-630, in the case of nsP2 from CHIKV, have been 
expressed and purified as recombinant proteins. Biochemical analysis has re-
vealed that these fragments possess NTPase and RTPase activities. Hydrolysis 
of NTPs or dNTPs and RTPase are divalent cation-dependent (especially Mg+2 
or Mn+2) (209, 210, 220). There are a number of signature motifs that have been 
mapped to the N-terminus of the proteins associated with these activities. These 
are located in a region between aa 167–470, which, according to bioinformatics 
predictions, is reported to contain two RecA-like domains indispensable for 
NTPase and RTPase activity (Fig. 10) (215, 223, 224). These RecA-like do-
mains contain seven classical motifs essential for NTP hydrolysis, of which 
Walker A (motif I) is marked by the signature sequence GSGK192S, Walker B 
(motif II) is distinguished by the landmark sequence D252E253, and motif VI,  
denoted by R416 known as the “arginine-finger,” represents the indispensable 
motifs that pivotally drive NTPase and RTPase reactions by interacting with 
different skeletal portions of the NTP molecule; therefore, these motifs are 
commonly called the “core” motif of NTPase (215, 225). In the case of 
recombinant proteins, replacement of the highlighted aa residues individually 
(or in combinations) indeed completely abolished NTPase and RTPase activities 
(209, 210, 215, 226). Interestingly, however, the infectious clones of SFV 
harboring a K192N mutation in nsP2 were reported to be infectious and capable 
of reverting this mutation, which has been reported to produce infectious virus 
progeny (Rikkonen, 1996). This finding is puzzling as experiments in our labor-
atory have shown that the corresponding mutation completely inactivates the 
replicase of CHIKV and the corresponding clone lacks infectivity (our un-
published data). A biochemical study reported that a recombinant protein corre-
sponding to aa 1–470 of SFV could carry out an RTPase reaction with a sub-
strate affinity (Km) of 3 μM and catalytic rate (Kcat) of 5.5/min and an NTPase 
reaction with Km of 90 μM and Kcat of 230/min. These data suggest that the 
affinity of the enzyme for the RNA substrate is approximately 30 times higher 
than that of the NTP molecules; in contrast, the catalysis rate of the NTP mole-
cule is approximately 42 times higher than that of the RNA triphosphates. The 
RTPase activity of nsP2 is essential for making precursor RNA for nsP1 to 
carry out final capping reactions (210). The role of the NTPase activity of nsP2 
in virus infection, however, is not clear.  
Sequence alignment categorized the alphaviral helicase as SF1 (227). The 
helicase activity of nsP2 is imperatively associated with its NTPase activity to 
power the RNA unwinding: NTP hydrolysis must drive the helicase activity. In 
case of SFV or CHIKV, full-length nsP2 has clearly been demonstrated to un-
wind dsRNA in a 5'-3'directionally biased manner. Interestingly, truncated 
forms of nsP2 (fragments ranging from aa 1–470 or aa 166-630) lack this 
activity completely (209, 215, 217). The NTPase activity of the protein corre-
sponding to aa 166-630 of nsP2 was also insensitive to the presence of oligonu-
cleotides. The C-terminal region of nsP2 (aa 471–798) contains two distinct 
domains; the first is the functionally active protease domain and the second is 
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the MTL domain. The latter cannot be active as an enzyme because it lacks 
classical structural elements required for methyltransferase activity; instead, it 
functions as part of a non-structural protease. To note, the lack of methyltrans-
ferase activity could be an excellent proxy for performing ancillary but im-
portant functionalities. Surprisingly, this most distant domain is crucial for 
RNA helicase activity. First, the pI of this domain is >10, which means that at 
approximately neutral pH it is heavily protonated, rendering it capable of bind-
ing the RNA. Second, there is indirect evidence that the MTL domain folds 
towards the NTD domain (pI < 6); this interaction could form a binding pocket 
for the RNA (Fig. 11). As this topic is central for the current thesis, it will be 
discussed in great detail in later sections (209, 215, 222).  
 
 
 
Figure 11. X-ray crystallographic structure of the protease domain of CHIKV adapted  
from the PDB ID 3TRK, showing the protease domain and the C-terminal MTL domain 
(222, 228). The protease catalytic center is also highlighted. Note that the MTL domain 
possesses a long loop connecting the protease and MTL domains. All the structures 
from the PDB throughout this thesis are modified using PyMOL (229). 
 
 
The peptidase activity of nsP2 is associated with its C-terminal region (aa 471–
798 of nsP2; Fig. 11 and 12). A study involving X-ray crystallography revealed 
that this region contains a papain-like protease domain and MTL domain fea-
turing an FtsJ like fold towards the extreme C-terminus of this protein. In the 
case of SFV nsP2, the C478 and H548 form the catalytically active center of the 
protease (Fig. 11). In corresponding studies, the protease domain has always 
been analyzed together with the MTL domain (222); indeed, the papain-like 
protease domain is apparently not active. This may be attributable to two rea-
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sons. First, the MTL domain can provide necessary structural support for the 
protease domain to be active. Second, it is also possible that expressing or puri-
fying only the protease domain could expose hydrophobic patch that otherwise 
would have been buried under or by the MTL domain, and this leads to the 
aggregation and inactivation of the recombinant protein. The latter hypothesis is 
supported by experimental evidence that suggests that nsP2 lacking only the 
MTL domain shows signs of aggregation in gel filtration chromatography pro-
file and CD spectroscopy (215). Although the MTL domain lacks any profes-
sional enzymatic activity, it is important not only for accommodating RNA (see 
above) but also for the regulation of protease activity. Furthermore, in the case 
of SINV, a genetic study suggested that positively charged conserved aa resi-
dues of this domain have broad functional implications towards minus strand 
RNA synthesis. Mutation 615A in the loop region of MTL also affected positive 
polarity viral RNA synthesis and resulted in viruses that could not inhibit host 
cell translation. Intriguingly, however, this mutation had minimal effects on 
cellular transcription or on viral polyprotein processing and minus strand syn-
thesis. This suggests that this residue could likely contribute towards the estab-
lishment of a functional replicase complex (230). Taken together, it could be 
concluded that the MTL domain has evolved to be more participatory rather 
than a direct role in any enzymatic or biological activity involving nsP2 (Fig. 
12) however, clearly our understanding of this domain is far from adequate to 
draw any bold conclusions regarding its purpose in the course of alphavirus 
infection.   
The protease activity of nsP2 is an important and essential requisite for the 
regulation of replication, which is associated with the processing of nsP1234 
(128, 131, 219). It has also been demonstrated from evidence of biochemical 
assay that the protease activity of nsP2 could be inhibited by divalent cations 
such as Zn+2 and Cu+2. However, Co+2 and Ni+2 partially block this activity, 
whereas Ca+2, Mg+2 and Mn+2 had no effect on the protease activity (231). The 
site between nsP123 and nsP4 (3/4 site, similar designations are used for other 
sites hereafter) is readily processed through an in cis cleavage during or just 
immediately after translation to release active nsP4. This is also the only pro-
cessing event that is absolutely required for virus infectivity and leads to the 
formation of negative strand replicase (nsP123 + nsP4) (117, 129, 130, 232, 
233). A second cleavage, again in cis, takes place at the 1/2 site. This cleavage 
regulates replication complex formation and affects cellular anti-viral responses 
and the ability of virus to counteract these cellular activities (unpublished data 
from our lab). This cleavage apparently leads to structural reconfiguration of the 
replicase complex and permits the involvement of additional transcriptional 
cofactors to provisionally switch synthesis towards positive strand viral RNA 
(117, 129). Finally, the 2/3 site is processed.  
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Figure 12. This picture has been adapted from (234), with an associated PDB ID 
4GUA, showing the pre-cleavage conformation of the nsP2/3 site of SINV. Different 
domains are color-coded; the protease and MTL domains belong to nsP2 while the 
macro domain and ZBD belong to nsP3. The scissile bond (cleavage site), the protease 
active center and a zinc cation are highlighted. Note that the protease active center is far 
away from the cleavage site, which supports the trans mode of cleavage of this particu-
lar site in alphaviruses. 
 
 
Both biochemical data and the 3D structure of the nsP2 protease domain indi-
cate that this can occur exclusively in trans (Fig. 12). Final cleavage leads to the 
liberation of all individual nsPs to commit their activities for viral replication; in 
many ways, it is a point of no return, which means that negative polarity viral 
RNA would no longer be synthesized (Fig. 12) (232). It has  been shown that 
for processing of the 2/3 site, short peptides representing cleavage site is not 
enough; a minimal substrate should contain a few aa upstream of the cleavage 
site and a large fragment ~170 aa from the N-terminus of nsP3. Unlike other 
cleavages, processing of the 2/3 site requires a full-length nsP2 protease with an 
authentic N-terminus; even minor changes at the N-terminus of enzyme are 
poorly (or not at all) tolerated (Fig. 23) (132). It should be noted that alphavirus 
mutants, which are unable to process the 2/3 site, are generally viable (although 
often have a temperature-sensitive phenotype). Commonly these mutants have 
an inability to shut down negative strand synthesis. This phenotype highlights 
another, possibly the most important, significant aspect of 2/3 site processing. 
Later in infection, when the nsP2 concentration in infected cells exceeds a cer-
tain threshold, the free protease starts to cleave nsP1234 between the 2/3 sites. 
As indicated in the sections above, it abolishes the formation of new replicase 
complexes and prevents negative strand RNA synthesis, leaving only the syn-
thesis of positive strand RNA active (135).  
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NsP2 of Old World alphaviruses such as SINV and SFV is also associated 
with cellular transcription and translation shutdown to induce cytotoxicity. The 
cessation of transcription and translation are independent events, as mutations 
such as P726 in SINV and P718 in SFV selectively relieve cellular transcription 
(65, 216, 235–237). Recently it has been shown that nsP2 of SFV, SINV and 
CHIKV inhibits cellular transcription by causing the rapid degradation of Rpb1, 
a catalytic subunit of the RNA polymerase II complex. This ability of nsP2 is 
specific for vertebrate cells and is blocked by mutations inhibiting NTPase or 
helicase activities of nsP2 but not by mutations blocking the proteinase activity 
of nsP2 (213). The SFV and SINV also take control of protein synthesizing 
machineries in the cell: after just a few hours of infection, all the translating 
machinery as well as related systems are directed towards the synthesis of viral 
proteins (mostly structural proteins). This is aided by employing ribosomes at 
the site of viral replication and by establishing interactions between nsP2 and 
ribosomal protein elements (78, 79, 237–240). Additionally, the nsP2 proteins 
of Old World alphaviruses can enter the nuclei of infected cells; this is required 
to cause Rpb1 degradation and also for blocking of antiviral interferon signal-
ing. It is, however, not clear how nuclear transport works. NsP2 of SFV is re-
ported to carry NLS (PRR649RV sequence). Indeed, mutations in this element 
block nsP2 translocation to the nucleus and abolish the ability of nsP2 to inter-
fere with interferon signaling. However, this effect is temperature-dependent 
(237), and corresponding regions of nsP2 of CHIKV (241) and SINV (242) do 
not contain functional NLS elements. Recently, it has been reported that nsP2 of 
CHIKV inhibits the unfolded protein response, a cellular defense mechanism 
against high concentrations of misfolded protein, in the host cell. Thus, nsP2 
interacts with many cellular processes (sometimes in a virus- or host-specific 
manner) and regulates viral RNA replication (166, 214, 216, 237, 242–251). 
 
 
3.1.7.3. Nonstructural protein 3 
NsP3 (53 kDa; 482 aa in SFV and 58 kDa; 530 aa in CHIKV) is the least under-
stood of the alphaviral ns proteins. However, recent revelations about the versa-
tility of its activities have necessitated focused investigations. NsP3 contains 
three different regions. The N-terminal 160 aa domain forms the macro domain 
(MD), while another 160 aa domain following this region is conserved among 
alphaviruses and has been recently classified as ZBD. The C-terminal-most 
region of nsP3 is known as the hypervariable region (Fig. 12, 13 and 14) (25, 
234, 252). NsP3, when expressed as a single protein, localizes to the cytoplasm, 
where it forms inclusions of random sizes. However, if nsP3 is expressed as a 
part of the nsP123 polyprotein, it localizes to the endosomal and lysosomal 
membranes. These structures, which are devoid of spherules, are still compara-
ble to the CPVs (145).  
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Figure 13. Schema of alphavirus nsP3 showing the macro domain, zinc binding domain 
and hypervariable region. Phosphorylation sites and the proline-rich region are high-
lighted (234, 253, 254). 
 
 
MDs are not only confined to viruses but have been found in many proteins 
from archaea, bacteria and also eukaryotes (255). MDs with an approximate 
representative size of 160 aa are also encoded by several other positive strand 
RNA viruses such as HEV, CoVs (including the SARS-CoV) and rubella virus 
(256). The crystallographic structure of MD from CHIKV and VEEV has been 
resolved. The proteins have been reported to be active as adenosine di-phos-
phoribose 1″-phosphate phosphatases, and a single aspartic acid residue is re-
portedly responsible for binding to the adenine base. This study also reports that 
MD engages the exposed positively charged patches, which are present distantly 
from the enzymatic active center, to interact with DNA, RNA and poly(ADP-
ribose). The specificity of these interactions still needs to be validated; however, 
a general conclusion is that MD is involved in the binding of RNA during viral 
replication (257). Interestingly, isothermal titration calorimetry analysis sug-
gested that MD of SFV could bind to poly(ADP-ribose) with considerable af-
finity, while it could not bind ADP-ribose; in contrast, the MD of CHIKV and 
VEEV binds ADP-ribose with low micromolar affinity (Fig. 14) (255–257). 
This finding is surprising because SFV is an Old World alphavirus and one of 
the closest relatives of CHIKV. Thus, it remains to be elucidated whether this 
finding could be attributed to the true and unique properties of SFV MD or is a 
result of the instability of purified recombinant protein (256). The MD, along 
with a few aa downstream of its C-terminus, has been shown to be very essen-
tial for the processing of the 2/3 site (132). 
The ZBD has a size comparable to MD (Fig. 12 and 13). Recent X-ray crys-
tallography data along with virological evidence has considerably elevated our 
understanding of the functions of this region. ZBD consists of an antiparallel 
alpha helical bundle, two parallel beta strands and a cysteine-rich zinc coordi-
nation site, positioned adjacent to the protease domain of nsP2 (Fig. 12). A 
mutation in the conserved zinc coordinating site results in less productive virus 
infection. Along with MD, this domain offers a long platform for RNA binding. 
ZBD was also proposed to play a critical role in switching template preference 
towards the synthesis of positive strand RNA after 2/3 site cleavage (Fig. 12) 
(232, 234).  
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Figure 14. The structure of the macro domain of CHIKV nsP3 (1-160 aa) complexed 
with short RNA (PDB ID 3GPQ). It has also been proposed that the same binding 
pocket can bind other negatively charged polymers such as poly(ADP-ribose) or DNA, 
as the binding is relatively unspecific (occurs due to the presence of a positively 
charged patch) (257). 
 
 
The C-terminal-most region of nsP3 is highly variable, not only in terms of 
sequence but also in its length; hence, it is called the “hypervariable region” 
(Fig. 13) (25). However, upon closer scrutiny, this region demonstrates some 
special arrangements. It contains repetitive short sequence motifs that are be-
lieved to interact with numerous host factors that are important for virus repli-
cation. In SINV-infected BHK-21 cells, nsP3 is found in different complexes, 
some of which are associated with the plasma membrane and endosome-like 
vesicles while others are also associated with nuclei (258). In the same study, it 
was shown that nsP3 of SINV (but not nsP3 of VEEV) binds to proteins in-
volved in stress granule formation such as G3BP1 and G3BP2 or to their homo-
log in invertebrate cells (Rasputin); these observations have been confirmed by 
several subsequent studies (258–260). Furthermore, it has also been shown that 
the proline-rich motif in the nsP3 of SFV, SINV and CHIKV interacts with 
amphiphysin; mutations changing these proline residues or silencing of am-
phiphysin expression affects viral RNA replication in HeLa cells (254). The 
proline-rich region of the hypervariable domain is not essential for G3BP1 
binding (261); instead, the interaction with G3BPs is mediated by repeated 
motifs located at the extreme C-terminus of nsP3. This region clearly possesses 
several other functions as well: it overlaps with the 3/4 processing site and is 
shown to carry a degradation signal for nsP3. Thus, removal of 10 aa from the 
C-terminus of nsP3 increased the half-life of nsP3 from 1 hr to 8 hr; more ex-
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tensive (40 aa) deletion in the same region also reduces the synthesis of sg RNA 
(262). It has also been demonstrated that nsP3 networks with vimentin, a 
filamentous protein found in non-epithelial cells, which surround and support 
the replication complex of CHIKV in infected cells (263). 
A stretch of serine and threonine residues is located between the ZBD and 
hypervariable region (~aa 320-350 for nsP3 of SFV). It has been shown that 
these residues are phosphorylated in host cells (Fig. 13) (264, 265). In the case 
of VEEV, phosphorylation of this region is reported to be dispensable in verte-
brate cells but not in insect cells. The entire hypervariable region of nsP3 is 
actually dispensable in BHK-21 cells: viruses harboring deletions in this region 
can recover just by acquiring one or two compensatory mutations. This has 
permitted the use of this region for the insertion of marker proteins. 
Furthermore, all hypervariable regions of nsP3 can be replaced with a 
heterologous protein, at least for VEEV. In the case of SINV, in which the 
phosphorylation of nsP3 is especially prominent, it has been shown that 
reduction in the levels of nsP3 phosphorylation is directly proportional to 
reduced levels of negative strand RNA synthesis (266, 267). 
 
 
3.1.7.4. Nonstructural protein 4  
NsP4 (~68 kDa; 614 aa in SFV and 611 aa in CHIKV) always has an aromatic 
Tyr residue at its N-terminus and possesses an unstructured N-terminal region 
(approximately 100 aa, unique for alphaviruses) and a C-terminal region that 
harbors RdRp activity (Fig. 15) (268–270). Mutational analysis of the N-termi-
nal region suggests that this region acts as an adaptor domain and is involved in 
interactions with other ns proteins. Curiously, it was also found that viruses 
containing mutations in this region are also unable to affect host cell translation 
(269). The C-terminal region of nsP4 contains a conserved signature motif with 
the signature sequence GDD which is strongly related to RdRps (Fig. 15). 
Based on sequence analysis, the alphavirus RdRp belongs to supergroup III, 
which also includes obamovirus, tobravirus, hordeivirus, tricornaviruses, beet 
yellows virus, rubivirus, furoviruses, HEV, potexvirus, carlavirus, tymoviruses, 
and apple chlorotic leaf spot virus (271). The crystal structure of the alphavirus 
RdRp has yet to be determined; however, it is very likely that this enzyme may 
have a “fingers-palm-thumb” structure characteristic of typical RdRps (272, 273).  
 
 
 
Figure 15. Schema of alphavirus nsP4. N-terminal disordered region, region required for 
terminal transferase activity and GDD catalytic motif for RdRp are shown (268, 274). 
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The alphavirus nsP4 is an unstable protein and this property is at least partially 
due to the presence of an N-terminal Tyr residue that leads to the rapid degra-
dation of free nsP4 by the proteasome (275, 276). The N-terminus itself is, how-
ever, absolutely required for the formation of functional replicases, as unpro-
cessed nsP1234 polyproteins form a nonfunctional replicase (128, 130, 277). 
Therefore, it is likely that rapid degradation of free nsP4 is used to maintain 
tight control over the production of nsP4. In addition, most alphaviruses down 
regulate nsP4 expression with an opal termination codon upstream of the region 
encoding nsP4. The read through of the terminator occurs with approximate 5–
20% efficiency (275, 278, 279). The N-terminal Tyr is not only needed to pro-
mote nsP4 degradation; it is also needed for nsP4 activity. Thus, Tyr can be 
replaced by any other aromatic aa or H or to some extent, M (270), while other 
residues at this position suppress the viability of the virus. The viruses harbor-
ing such mutations can, however, recover by acquiring compensatory mutations 
in nsP1 or in nsP4. These data again strongly suggests that the N-terminus of 
nsP4 is involved in a productive interaction with nsP1 during the initiation of 
minus strand synthesis. Interestingly, a follow up study described one more 
possibility to compensate for a non-aromatic residue at the N-terminus of nsP4. 
In this case, compensation is achieved by including an extra 3'-UA-5'-rich re-
gion into a putative promoter site for the initiation of positive polarity RNA 
synthesis. This finding corroborates the notion that the N-terminus of nsP4 is 
also involved in the initiation of genomic RNA synthesis (204, 280). 
The alphaviral nsP4 has also terminal TATase activity; the enzyme prefer-
entially adds adenine nts to the 3' end of RNA. This activity is likely necessary 
for synthesis, maintenance and repairs of the poly(A) tail, which cannot be 
synthesized in a template-dependent fashion (Fig. 15). This activity was first 
demonstrated for purified SINV nsP4 devoid of 97 aa at the N-terminus 
(nsP4del97). Mg+2 or Mn+2 -dependent TATase activity was abolished by a 
GDD to GAA mutation in the catalytic center of nsP4 (Fig. 15) (274). It has 
also been shown that in the case of SINV, nsP4 could add poly(A) or AU-rich 
regions to the ends of defective or damaged viral genomes (281).   
It was later shown that the N-terminal region, which was missing in the 
original recombinant protein, holds some importance as its presence considera-
bly increased TATase activity. This sequence was, however, strictly required 
for the RdRp activity of nsP4: in the presence of nsP123, the purified nsP4 with 
the correct N-terminus (but not nsP4del97) was able to synthesize negative 
polarity RNA. This synthesis was abolished by mutations in the 3' CSE and 
poly(A) region. Combined, these data indicate that the unstructured N-terminal 
region of nsP4 is involved in efficient RNA recognition. It has also been shown 
that individual nsP4 (thus, in the absence of other viral ns proteins) is still 
capable of transcribing positive and negative polarity viral RNA but not sg 
RNA. Therefore, it can be suggested that the N-terminal region could be in-
volved in a decisive, but regulated, interaction with nsP123 that may lead to an 
altered conformation preferring specific promoter recognition and subsequent 
synthesis of a particular polarity of RNA over others (268, 269, 282).  
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RNA-protein crosslinking experiments have shed some light on promoter 
recognition by alphaviral nsP4. It has been shown that sequences of the nsP4 
molecule, used for the recognition of promoters for sg and genomic RNA syn-
thesis, are different. In the case of SINV, the sg promoter is recognized and 
bound by peptide 329LVRRLT334, while peptide 531LGKPLPAD538 is used 
for recognition of the genomic promoter. Importantly, data from crosslinking 
experiments were clearly supported by reverse genetic experiments. Thus, 
changing the R residues at positions 331 and 332 affected only the synthesis of 
sg, not the genomic RNA (283–285).  
In the course of alphavirus infection, the synthesis of negative or positive 
polarity viral RNA is regulated by ns polyprotein processing. When nsP4 and 
unprocessed nsP123 form the early replication complex, mostly negative polar-
ity viral RNAs are synthesized. This indicates that the complex recognizes pro-
moter elements for negative strand synthesis in the positive polarity genomic 
RNA. In contrast, the late replicase complex consisting of mature nsPs does not 
normally recognize the promoter for the synthesis of negative strand RNA but 
rather only the promoters for positive polarity RNA (129, 130, 232, 233, 277). 
These findings strongly suggest that not only the existence of differential recog-
nition elements on the same nsP4 molecule is important for alterations in pro-
moter specificity but this is also affected by fine-tuned conformational changes. 
These changes may be triggered by protease cleavage to ensure the synthesis of 
viral RNA of the appropriate polarity. However, it is more likely that confor-
mational changes (or parts of them) actually occur prior to proteolytic cleav-
ages, which are used to make these changes essentially irreversible. If so, these 
proteases are tools to recognize the changes, not tools to make them happen. 
This hypothesis is in line with the observation that SINV, harboring non-cleav-
able nsP123 and one compensatory change in nsP4, is capable of synthesizing 
RNAs of both polarities (247). Similarly, some temperature-sensitive mutants of 
SINV are capable of re-activating negative strand synthesis even in the presence 
of inhibitors of protein synthesis (286). Thus, the regulation of viral replicase 
complex specificity is not rigid, and the same end results could be achieved 
using different approaches.  
 
 
3.1.8. Alphavirus-based vectors  
Alphavirus-based vectors represent promising tools in the field of gene therapy, 
cancer treatment and vaccine development (287). These vectors are widely 
studied and used. As these constructs are based on RNA, regulatory elements, 
which almost exclusively originate from the “DNA world,” cannot be used for 
these vectors. Nevertheless, there are multiple options to control and regulate 
gene expression with these vectors. For example, alphavirus gene expression (at 
least for SFV and SINV) could be regulated using different strategies such as 
using a capsid enhancer sequence (77, 152, 288).  
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The advantage of alphavirus vectors over other viruses derives from its very 
basic characteristics, such as the production of high-titer virus stock in a rela-
tively short period of time, a broad host range, a high rate of RNA replication 
and transient gene expression (289–291). In anti-tumor and anti-microbial treat-
ments, the drawbacks, which are intrinsically related to alphavirus infection 
(such as the shutdown of host cellular machineries, induction of programmed 
cell death and short term mode of expression) could actually be advantageous 
for such therapies (292). Mutations in the viral ns proteins could be used to limit 
RNA replication and to develop non-cytopathic replicons (the term replicon is 
used to indicate self-replicating RNA that cannot form infectious virions); such 
RNAs are capable of persistent replication in mammalian cells (293). Such 
mutations are most often mapped to nsP2; however, several manipulations in 
the nsP3 or nsP1 region can also reduce the cytotoxicity of alphaviruses and 
their replicons (195, 265, 294–297). Alphavirus vectors can also be used for 
basic studies. For example, such vectors have an added advantage in neural 
research as these constructs can be used specifically for the infection of neural 
cells. Such an approach may result in a high percentage (> 90%) of GFP-posi-
tive neuronal cells, while glial cells may remain uninfected (287, 298). 
As briefly mentioned above, alphavirus-derived replicon vectors are con-
structed by replacing the structural portion of the genome with multiple cloning 
sites. Thus, these vectors contain a natural ns protein-encoding region and all 
CSEs (including the sg promoter), which are essential for replication and tran-
scription. The viral replicon particles, which are similar to alphavirus virions 
(except that they contain replicon RNA instead of the viral genome), could be 
produced by co-transfecting cells with in vitro transcribed replicon RNA and 
helper RNAs used for the synthesis of the structural proteins (290, 299). The 
expression of foreign genes could be performed by transfecting these engi-
neered RNAs directly into the cytoplasm or infecting cells with viral replicon 
particles carrying corresponding RNA. In many cases, the fact that replicons are 
limited to the infected (transfected) cells and cannot escape to infect nearby 
cells is beneficial. To ensure this, the packaging signals were purposefully de-
leted from helper-RNAs making replicons of single-cycle vectors. As many 
alphaviruses are pathogenic for humans, the safety of alphavirus replicons is an 
important concern. Indeed, as replicons and helper-RNAs contain identical 
sequences, there is risk that these two RNAs may recombine, resulting in wt 
virus. Multiple approaches can be used to reduce such risk. The most straight-
forward approach is to split the coding region for structural proteins into capsid 
and glycoprotein portions resulting in two helper vectors. This manipulation 
greatly reduces the probability of successful recombination (300–303).  
Another type of alphavirus vector, called a “marker virus,” has been con-
structed and studied. In these cases, the foreign gene (most commonly a marker 
gene such as EGFP) is inserted into the structural or ns portion of the virus 
genome, or its expression is derived from an extra copy of the sg promoter 
(sometimes also by IRES from another virus). For example, one such vector 
based on the SINV genome has EGFP linked to “auto-cleaving” 2A sequence 
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from foot-and mouth disease virus, placed in between the capsid and E3 
regions. This virus is claimed to show more stability than the analogous vectors 
containing a duplicated sg promoter (304). Comparable work has been carried 
out by different research groups by inserting a marker gene into the replicase 
portion of the SINV genome; the obtained viruses have been used to study the 
inhibition of alphavirus replication, nsP3-specific complex formation and 
functions related to nsP2 (305–307). It should be mentioned that the design of 
such recombinant genomes cannot always be used for different viruses. For 
example, an SFV construct similar to that described by Thomas et al. (2003) 
suffers from instability and is completely avirulent for mice (308). While 
studies were not able to construct a recombinant SINV with EGFP inserted into 
the nsP1 protein, such constructs were obtained for both CHIKV and SFV 
(unpublished data from our lab). Regardless, the number of approaches that 
could be used to improve alphavirus-based expression systems is nearly endless. 
Systems may be engineered to achieve high-level and long-lasting expression of 
heterologous proteins (309), to increase cell-type specificity of the virus (310) 
and other functions. 
 
 
3.2. Helicases 
3.2.1. Introduction to Helicases  
Helicases are NTPase or dNTPase enzymes that are capable of unwinding ds 
NA into its component single strands. Helicases can also be viewed as subsets 
of “translocases”: enzymes that are capable of hydrolyzing nts to directionally 
travel on nucleic acids with or without unwinding them. Thus, all helicases can 
be translocases but the reverse may not hold true (225, 311, 312). For example, 
RIG-I, EcoR124I, SWI/SNF, and ISW2 are all translocases but do not possess 
helicase activity (313). Helicases are processive enzymes that are capable of 
carrying out multiple cycles of catalysis before releasing the product. This is 
different from distributive enzymes such as simple NTPases that undergo one 
round of catalysis and release the product to bind a new substrate (225).   
Helicases were discovered close to 40 years ago. The first report of an en-
zyme of such type appeared in 1976: an enzyme from the Gram-negative bacte-
rium E.coli that unwound DNA in an ATP-dependent manner was described. 
The authors of this article state that “the enzyme was found to denature these 
duplexes in an ATP-dependent reaction, without detectably degrading” (314). 
First, eukaryotic helicase (from meiotic cells of Lilium) was reported in 1978; in 
this study, the authors termed this enzyme as “DNA unwinding protein” or “U-
protein” (315). Since then, helicases have been discovered in all forms of life. 
Their functions are not only confined to the unwinding of nucleic acids; it has 
been understood that they play a much greater and complex role in the metabo-
lism of NA including protein displacement from DNA and RNA, remodeling of 
chromatin, DNA replication and repair, transcription, translation, ribosome 
51 
 
biogenesis, maturation of RNA, splicing, and nuclear export processes (312, 
316). Furthermore, the importance of these enzymes can be highlighted by 
considering the number of diseases associated with their malfunctioning (317–
321). Helicase has also been proposed as a drug target to limit viral infection 
(322–324).  
Helicases often exhibit polarity or directionality, which demonstrates the 
unidirectional manner in which the helicase may unwind and/or translocate on 
the NA. Given the structure of NA, the direction could be a 5'-3' or 3'-5'; there 
have also been reports of bidirectional or bipolar helicases that can unwind NA 
in both directions. Examples of such enzymes are eukaryotic translation initia-
tion factors and RH70, which unwinds RNA in a bipolar manner (325–327). 
Common differences between DNA and RNA helicases concern their processivity: 
- DNA helicases tend to be more processive: they often translocate or unwind 
multiple basepairs before dissociating.  
- RNA helicases are relatively less processive and typically act as NTP-
dependent chaperones by binding and remodeling RNA to form a more pro-
ductive conformation (312, 328). 
 
 
3.2.2. Classification of Helicases 
Helicases can be classified mechanistically on the basis of some of the very 
general features such as: 
- Substrate specificity: whether the helicase acts exclusively on RNA, DNA or 
both or on RNA:DNA hybrids 
- Directionality: whether it moves and unwinds in a 3'-5' (class A) or 5'-3' 
(class B) direction 
- Whether the helicase is a bona fide unwinding machine or a simple trans-
locase  
- Whether the helicase molecule forms a toroid or ring around NA 
 
However, these classifications are very broad, which provides minimal infor-
mation about the individual helicases; therefore, such groupings are very rarely 
used in the helicase research community (225, 311).  
The most robust and withstanding classifications are based on the enzyme 
sequence and structural information. Based originally on the sequence align-
ment and presence of at least seven signature motifs (motif I, Ia, II, III, IV, V, 
VI), Gorbalenya and Koonin classified helicases into three Superfamilies (SFs) 
and two families of putative helicases (316). Since then, many new helicases 
have been reported. Furthermore, there are also several putative helicases; these 
enzymes have NTPase activity but lack genuine NA unwinding activity. There-
fore, the original classification was again amended in 2007 by Singleton et al. to 
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accommodate these new helicases. Furthermore, the newer classification does 
not rely exclusively on the primary sequences of the enzymes; the available 
structural information with approximate 3D structures and additional newly 
discovered motifs (TxGx, Q-motif, motif4a, TRG) were also taken into account. 
Based on this, helicases are now classified into 6 SFs (SF1-6). SF1 and SF2 are 
monomeric helicases that contain two RecA-like folds on the same polypeptide 
chain. In contrast, SF3-6 are usually hexameric helicases that comprise six indi-
vidual RecA-like folds (each subunit or polypeptide contributes one of these 
folds) (224, 225). The above mentioned sequence motifs have been shown to 
represent signature peptide sequences present in the domains with the RecA-
like folds or in between RecA-like subunits. All of these motifs contribute to the 
binding and hydrolysis of NTP molecules (329). However, out of seven motifs, 
Motif I (Walker A) and Motif II (Walker B), both of which bind to NTP, and 
motif VI (arginine-finger; important for energy coupling) contribute pivotally to 
the “Core Domain” of the helicase. Accordingly, mutations in these three motifs 
commonly result in a NTPase-negative enzyme (330, 331). A brief description 
for each SF is provided below; however, special emphasis has made on SF1, as 
alphavirus nsP2 helicase belongs to this group. SF2, to which the other hel-
icases of RNA viruses (such as NS3 of HCV and DENV) belong (227), is also 
reviewed in a more detailed manner. 
 
 
3.2.2.1. Superfamily 1  
Helicases from SF1 have been extensively studied. They unwind NA either in a 
3'-5' or 5'-3' direction. This SF includes prokaryotic (bacterial) helicases such as 
Rep, UvrD, PcrA, RecD and Dda, which are generally well-studied. It also in-
cludes relatively less-studied eukaryotic helicases such as Upf1, Pif1, Rrm3 and 
viral helicases from alphaviruses (nsP2), CoV (ORF-1b), HEV (ORF-1), and 
Rubivirus (p220) (225, 332–337). Thus, SF1 could be further classified into 
class A, which includes 3'-5' directional helicases, and class B, which includes 
5'-3' directional helicases.  
 
 
3.2.2.1.1. SF1 of class A 
Crystal structures of the 3'-5' directionally biased PcrA (Fig. 16) and Rep hel-
icases have been determined. These structures revealed that these molecules 
consist of two domains, each of which can be further subdivided into two sub-
domains. The NTP binding site is situated in a cleft at the bottom of two RecA-
like domains classified as 1A and 2A in PcrA. This region contains conserved 
motifs for binding and hydrolysis of NTP molecules (Fig. 16) (335, 337). It has 
also been observed that the minimum structural requirement for NTP hydrolysis 
and thereby for fuelling helicase activity is present in just two RecA-like do-
mains. However, the other sub-domains, which are distantly present from the 
core RecA-like domain (1B and 2B in the case of PcrA) and probably do not 
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contribute directly to NTP hydrolysis, may nonetheless be important in un-
winding activity as they could interact with the NA (Fig. 16) (337). These NA-
binding domains, which could also be termed as “accessory domains,” act by 
coupling NTP hydrolysis with large conformational changes along the NA (335, 
338). It has been shown further that deletion of the 2B domain, which acts as an 
auto-inhibitor of the full-length Rep monomer, activates the helicase activity of 
the Rep monomer (normally the Rep monomer is relatively less processive than 
the usual dimerized enzyme) (339). However, a recent study proposed that 2B 
domain play a regulative role in case of Rep helicase; locking this domain in a 
closed conformation made Rep a monomeric super helicase (340). 
 
 
Figure 16. PcrA helicase from Bacillus stearothermophilus (337) and PDB ID 1PJR. A) 
The X-ray structure of the monomeric PcrA reveals omnipresent RecA-like domains 
and an ATP binding site. B) Schematic representation of the domain organization of 
PcrA; note that how distantly present sequences in the primary structure belong to the 
same or a single domain in the X-ray structure.  
 
 
3.2.2.1.2. SF1 of class B 
The structural and biochemical data for RecD from the RecBCD complex and 
biochemical evidence from studies of the Dda helicase contribute towards our 
understanding of SF1 helicases, which move in a 5'-3' directionally biased man-
ner (Fig. 17) (225, 336, 341–344). The NTP binding and hydrolysis between 
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class A and B helicases are strikingly similar. The main differences derive from 
the mode of their interaction with the NA.  
 
 
 
Figure 17. The 5'-3' SF1B Dda helicase (PDB ID 3UPU) from T4 phage co-crystallized 
with an ssDNA substrate. Domains 1A and 2A are the Rec-like domains, while the 
domain 1B, known as the 'Pin' domain, is required for the separation of dsDNA strands, 
which interact with the SH3 domain present primarily on domain 2B (342). 
 
 
The well-studied RecD is part of the RecBCD heterotrimeric complex. There-
fore, it is possible that the structural arrangement of this helicase may be 
evolved to complement the formation of the trimeric complex, and its structural 
conformation may not be fully comparable to those helicases that can act as 
monomers. This assumption is indeed supported by analysis of the crystal 
structure of RecD. The structure revealed the presence of an additional N-termi-
nal domain (NTD; in heterotrimers, it is oriented toward the RecC subunit) that 
is not present in the Dda helicase (Fig. 17). Furthermore, RecD itself does not 
contact with the NA, as this interaction is mediated by the RecB subunit. Again, 
it is different for Dda. Thus, parallels between RecD and Dda outside the core 
RecA-like domains may or may not exist (225, 336, 343). Under single cycle 
conditions, it has been shown that the Dda helicase (Fig. 17) can unwind DNA 
as a monomer. However, irrespective of monomeric or dimeric structure, there 
is strong evidence that helicase molecules of SF1 can cooperatively unwind NA 
substrates; this results in enhanced processivity and productivity (225, 343). 
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3.2.2.2. Superfamily 2  
SF2 is the largest SF of helicases and includes at least 10 subfamilies of hel-
icases such as RecQ-like, RecG-like, Rad3/XPD, Ski2-like, type I restriction 
enzyme, RIG-I-like, NS3/NPH-II, DEAH/RHA, DEAD-box, and Swi/Snf fam-
ilies. SF1 and SF2 share the comparable core RecA-like domain for binding and 
hydrolyzing NTP molecules. However, distinct structural differences between 
these two families exist (225, 311). These are illustrated below with examples 
of helicases from the DEAD-box and NS3/NPH-II subfamilies (313). 
 
 
3.2.2.2.1. DEAD box Helicase 
The name of this group derived from the conserved peptide sequence repre-
senting motif II (DEAD stands for Asp-Glu-Ala-Asp). This is the largest group 
in SF2 and includes helicases from prokaryotes to higher eukaryotes (345). The 
helicases from this group are mostly involved in activities concerning RNA 
synthesis and functioning, including transcription, splicing, transport, ribosome 
biogenesis, translation, RNA/protein complex assembly, and degradation (313). 
Therefore, these enzymes are mostly ATP-dependent RNA chaperones that may 
not translocate or unwind ds NA processively. The landmark property of these 
enzymes is that their activity is enhanced upon binding to RNA. Generally, this 
binding occurs distantly from the unwinding active center of the enzyme (313, 
346, 347). The protein from DEAD box family binds RNA in an ATP-depend-
ent manner. However, as stated above, the protein does not translocate on the 
RNA but rather manipulates or remodels the structure of the RNA locally via 
protein-RNA interactions. This type of RNA remodeling involves strand re-
winding and unwinding by prying of the individual strand. Thus, these enzymes 
can unwind only very short duplexes without any directionality (313, 348–351).  
The DEAD box proteins are mainly comprised of two domains, both of 
which are primarily RecA-like domains. Certain fine-tuned features were dis-
covered in these proteins, which specifically interact with nucleotides and RNA 
polymer (313). Motifs I-III belong to the N-terminal RecA-like domain, while 
motif IV-VI belong to the C-terminal Rec-A-like domain (348). A specific Q-
motif, present in these proteins, interacts specifically with the adenine base of 
the ATP (352). The two Rec-A-like domains take an open conformation in the 
absence of ATP and RNA, while the domains close upon binding of these mol-
ecules (353, 354). In the case of DEAD proteins Ded1p, Mss116, and eIF4A, it 
has been shown that these proteins are capable of unwinding duplex RNA in the 
presence of non-hydrolysable ATP analogues such as ADP-BeF3 but not in the 
presence of ADP-AlF(4) or ADPNP. Thus, ATP binding but not its hydrolysis 
is necessary for strand separation. However, it has been shown that ATP hy-
drolysis leads to enzyme recycling, which could proceed through different de-
grees of affinity towards RNA (313, 349, 355–357). 
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3.2.2.2.2. NS3/NPH-II-like Helicase  
This group includes a number of helicases from positive strand RNA viruses, 
mostly from the family Flaviviridae: the best studied examples are NS3 hel-
icases of HCV (Fig. 18), DENV, WNV, YFV, and Japanese encephalitis virus.  
 
 
Figure 18. 3D structure of HCV NS3 helicase domain in complex with an ssDNA 
oligonucleotide. Domains 1 and 2 resemble classical RecA-like domains. A sulfate ion 
is bound to the ATP binding site. The ssDNA is bound in the channel between these two 
domains and the third (NA-binding) domain (358, 359) and PDB ID 1A1V. 
 
 
The NS3 proteins from these viruses harbor helicase activity in their C-terminal 
region; the N-terminal region has peptidase activity. A few studies have sug-
gested that communication exists between these two functionally different re-
gions, which are important for helicase activity. Another extensively studied 
viral helicase from this group is NPH-II, which belongs to Vaccinia virus (VV) 
from the family Poxviridae (311, 313, 360–364). The NS3 helicase (Fig. 18) 
acts both on DNA, RNA and DNA:RNA hybrid substrates with a 3' ss region. 
In contrast, NPH-II prefers substrates with a RNA loading strand (313, 365–
369). It has been shown that nicks in the loading strands pauses the enzyme 
when it is still engaged in the process of unwinding. Thus, these enzymes prefer 
to track on one strand while excluding the other strand (370, 371). The 3D 
structure of the NS3 helicase of HCV (Fig. 18) has been known for many years 
and has been intensively studied (359, 365, 369, 372, 373). This protein (and 
others similar to it) is likely to crystallize, a hypothesis that is supported by 
bioinformatical analysis of the NS3 primary sequence on the Xtal-pred server 
(374). All structural studies have shown that the NS3 helicase consists of three 
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domains: two RecA-like domains (named domain 1 and 2) and NA-binding 
domain 3 (Fig. 18). The NA is held in an electrostatic pocket formed between 
the two RecA-like motor domains and a 3rd domain (Fig. 18) (365).   
  
 
3.2.3. Hexameric Helicases 
The SF1 and SF2 helicases can function as monomers, indicating that a single 
polypeptide can fold to form an NTP binding and hydrolysis domain as well as 
the NA binding domains. The ring-shaped (or toroid) helicases, which are clas-
sified as SF3, SF4 (DnaB-like), SF5 (Rho/V-F-ATPases), and SF6 (AAA+: 
ATPases Associated with various cellular Activities), are considerably different 
both structurally as well as mechanistically from the first two SFs. The ring-
shaped helicases are usually hexamers containing six identical or different sub-
units and are therefore called homohexamers (e.g., MCM complex from archea) 
or heterohexamers (e.g., MCM complex from eukaryotes), respectively (375–
377). Each properly folded polypeptide, representing one subunit of hexamer, 
contributes the aa residues for the Walker A and B motifs, while the arginine 
finger motif comes from the neighboring subunit; thus, the NTP binding and 
catalysis centers are formed from elements belonging to different subunits (225, 
378). The hexameric helicases are often associated with NA metabolism pro-
cesses such as replication (e.g., T7, T4, and SPP1 helicases in bacteriophages), 
recombination (e.g., bacterial RuvB protein) and transcription (e.g., bacterial 
rho protein) (379). The topological contacts formed by these toroid enzymes 
with the DNA molecule empower these enzymes to be highly processive ma-
chines on the DNA. There are very well-controlled mechanisms that regulate 
how these oligomeric protein molecules load themselves onto the DNA mole-
cule. These include controlled binding of NTP or Mg2+ (or both), which leads to 
the formation of hexamer. Binding of NTP and the hexameric form is necessary 
for DNA loading, which in turn stabilizes the complex further. Finally, DNA 
binding leads to the stimulation of NTPase activity of the enzyme, and, through 
an energy transduction process, NTP hydrolysis is coupled to the unwinding 
activity. Each of these steps contributes to additional pivotal regulation of the 
activities associated with these enzymes (379). These functional and regulatory 
events are clearly important. This is evidenced by a human genetic disorder 
known as Bloom's syndrome, which is concomitant with the disruption of one 
of the eukaryotic hexameric helicases, leading to chromosomal instability 
through an unknown mechanism (225, 379–383).  
 
 
3.2.3.1. Superfamily 3 
SF3 helicases were first reported in small DNA and RNA viruses in which these 
proteins not only contribute to the unwinding of NA but are also involved in the 
binding of replication origins and initiation or replication. These helicases form 
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hexamers or double hexamers and unwind NA in a 3'-5' (Type A) direction. SF3 
includes helicases from Simian virus 40 (SV40), adeno-associated virus (AAV) 
type 2, and human papillomavirus type 18 (HPV18), which represent well-
studied examples of enzymes of this type (225, 378, 384–388). Originally, three 
sequence motifs, known as A, B, and C, were identified in each subunit in a 
stretch of just ~100 aa. Later, a motif known as B' was identified between mo-
tifs B and C. Thus, in the case of SF3, just approximately 100 aa residues con-
tain all four conserved motifs. The motifs A and B are equivalent to the classi-
cal Walker A and Walker B motifs of SF1 or SF2, while motif C (Asn residue 
placed downstream of a hydrophobic stretch) is SF3-specific. The crucial argi-
nine finger is present after motif C (225, 385, 389). The arginine finger senses 
the presence of the γ phosphate of the NTP bound to the neighboring subunit 
via the Walker A and B motifs (223, 378). The core domain of the SF3 hel-
icases has structural similarity to the AAA+ class of proteins (broader group of 
ATPases and Walker type NTPases, which are mostly involved in protein fold-
ing complex disassembly, protein transport, and protein degradation) rather than 
to the RecA-like domains of SF1 and SF2 (378) (390, 391). The AAA+ module 
contains two domains at the N- and C-termini. The N-terminal domain has al-
pha-beta-alpha folds and an nt binding pocket formed by the classical Walker A 
and B motifs, while the C-terminal domain is purely alpha helical. The N-ter-
minal domain resembles a RecA-like fold, which carries parallel beta sheets 
flanked by alpha helices (224, 329). Walker A is present as a loop (P-loop) 
connecting beta strand 1 and alpha helix 2, while Walker B is present on beta 
strand 3 consequent of the P-loop (Fig. 19). The all-alpha C-terminal domain is 
less conserved across the AAA+ class of NTPases and is proposed to stabilize 
the hexamer (225, 390–392). The conserved NTPase motif is preceded by an 
origin (Ori) DNA binding domain (225, 378). 
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Figure 19. The hexameric Bovine papilloma virus (BPV) E1 helicase showing the ar-
rangement of individual AAA+ subunits. A) Each subunit (1–6) is color-coded for rep-
resentation. The ADP and Mg ions are bound to the interface between the subunits, 
while ssDNA is bound in the central channel. B) Lateral view of the BPV E1 helicase. 
The structure shows the oligomerization domains, which protrude out from the helicase 
(AAA+) domains and strongly interact with each other. This leads to the formation of a 
rigid collar which is proposed to contribute to the processivity of E1 helicase (393, 394) 
and PDB ID 2GXA. The author of the relevant article has reported two hexameric hel-
icases bound to ssDNA; however, for the purpose of simplicity, only one has been pre-
sented here. 
 
 
The papilloma Virus E1 hexameric helicase has been crystallized with a 13-nt-
long ssDNA and ADP. The obtained structure revealed that oligomerization 
domain forms a sixfold symmetry collar while the AAA+ domains locate radi-
ally to the collar (Fig. 19). The central channel forms the ssDNA binding 
groove (Fig. 19), where a specific interaction between the B' motif and the 
phosphodiester backbone of DNA has been reported to exist. It has been pro-
posed that the hexameric helicase has 6 ATP binding sites between subunits 
with three different conformations. These are interpreted to be moving around 
the ring at any point in time during the unwinding process: two places could be 
occupied by ATP (ATP-type conformation), while another two could carry 
ADP (ADP-type conformation) and last two may be empty (empty-type con-
formation). The position of the DNA binding loop reflects the class of the nt 
binding site. Thus, the ATP-type loop interacts towards the 5' end of the DNA 
while the ADP-type loop would interact with the DNA just below the ATP-type 
loop, and the empty-type loop places itself at the bottom of ADP-type loop on 
the DNA. The DNA is bound by multiple subunits: from one side there are 
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interactions with ATP-type loops, while from other side interactions with the 
empty-type loop occur. The loops move downwards with each catalysis of ATP, 
pulling the DNA with it; without ATP, it reverses itself to the top position to 
bind a new ATP molecule. The regulation and coordination of ATP hydrolysis 
between different subunits is supported by multiple interactions formed by the 
oligomerization domain, which safeguards the hexamer to continue to surround 
the ssDNA (Fig. 19). Recent evidence from single molecule experiments sug-
gests that E1 unwinds DNA by a strand exclusion mechanism and that the N-
terminal part of the helicase molecule surfaces towards the replication fork 
(225, 393, 395). 
 
 
3.2.3.2. Superfamily 4 
Helicases belonging to SF4 are primarily replicative helicases from bacteria and 
bacteriophages. In the bacterial system, the helicase is associated with primase 
activity. These functions reside in two separate polypeptides, e.g. DnaB and 
DnaG of E. coli or, as in the case of certain bacteriophage, in a single polypep-
tide. The helicase activity possesses a 5'-3' polarity, e.g., gp4 of bacteriophages 
T7 and T3 and alpha protein of bacteriophage P4. SF4 possesses five signature 
motifs designated H1, H1a, H2, H3 and H4 (396). Of these, the H1 and H2 are 
comparable to the classical Walker A and Walker B motifs, while other motifs 
have no comparable partners in other helicases (H3 often carries conserved Gln 
or in some cases His residues and has been proposed to be comparable to motif 
3 of SF1) (225).  
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Figure 20. T7 gp4 is a heptameric primase-helicase. A) Top view showing primase 
domains (blue) and helicase domains (red). The DNA binding loop of the helicase do-
mains are shown in cyan and are projected towards the central channel to bind dsDNA. 
The ring is essentially formed by the helicase domains with delicately associated pri-
mase domain. B) Side-view of gp4 shows crown-like shape of the complex (397) and 
PDB ID 1Q57. 
 
 
The gp4 of phage T7 has been intensively studied, and the crystal structure of 
this enzyme has been obtained. It reveals the arrangement of subunits as hex-
amers (or heptamers) in which the primase domain is loosely staged over the 
helicase domain (Fig. 20) (382, 397). Interestingly, the polypeptide, which only 
supports NTPase activity, has also been crystallized; it is a helical filament with 
a RecA-like fold (398). The optimal arrangement of these subunits to couple the 
hydrolysis of NTP with translocation is still unclear; however, it could be sug-
gested that cooperativity as well as regulatory control should exist between nt 
binding and DNA unwinding. Other SF4 helicases such as RSF1010 and E. coli 
DnaB have sixfold symmetry; in the case of the latter, threefold symmetry has 
also been reported (399, 400). 
 
 
3.2.3.3. Superfamily 5 
SF5 helicases exemplified by the Rho protein of bacteria closely resemble SF4 
helicases; however, due to sequence differences these were assigned to a new 
SF. Rho is responsible for terminating RNA transcription in E. coli. It interacts 
with a signature sequence on the newly synthesized RNA strand and then unwinds 
the RNA:DNA hybrid resulting from the transcription process (Fig. 21) (225).  
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Figure 21. 3D structure of Rho helicase, the transcription terminator factor of bacteria. 
A) The hexameric arrangement of Rho subunits (A-F). Each subunit is color-coded. The 
primary RNA binding site is highlighted on the N-terminal domain, while the secondary 
RNA binding site is present towards the interior (center of the ring), to which the C-
terminal domain of each Rho subunit contributes. Note that the Rho is an open hexamer 
rather a closed hexamer. B) Side view of Rho hexamer showing the N- and C-terminal 
domains and the ATP binding site (401) and PDB ID 1PVO. 
 
 
Cryo-electron microscopy suggests that in the absence of RNA, the Rho protein 
(at a low micromolar concentration range) forms heterogenous complexes. In 
the presence of RNA, however, a predominantly hexameric arrangement of Rho 
subunits has been reported. The hexameric state could possess a “closed or 
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notched” conformation. In the same report, a small subpopulation of Rho was 
reported to have a dodecamer arrangement (402). However, a subsequent 
crystallographic study reinforced the hexameric arrangement of Rho subunits 
and identified two RNA binding sites on each Rho subunit (Fig. 21). The first 
site is responsible for mRNA recognition, while other contributes towards 
mRNA translocation. Interestingly, the global conformation of Rho is not 
closed but is split open (Fig. 21); it has been proposed that this facilitates 
mRNA loading (401).  
 
 
3.2.3.4. Superfamily 6 
Members of this SF mainly form hexameric arrangements; however, they can 
be heterohexamers as observed for eukaryotic MCM 2-7 or homohexamers as 
observed in the case of archaeal MCM. In the case of the eukaryotic complexes, 
only MCM 4,6,7 heterohexamers have been reported to possess helicase activ-
ity; this activity is involved in initiation and elongation during DNA replication 
(225, 376, 377). The available structural information for this SF is primarily 
derived from archaeal MCM. Methanobacterium thermoautotrophicum has only 
one MCM-like gene (ORF Mt1770), and it resembles the MCM 4 of eukaryotic 
cells. The purified archaeal MCM appears to form a double hexamer with an 
approximate molecular mass of 850 kDa and has ATP-independent DNA bind-
ing and DNA-stimulated ATPase activity. It also possesses processive 3'-5' 
polarity DNA unwinding activity (375). Electron microscopic reconstruction of 
these molecular machines shows that monomers are arranged to form hexameric 
complexes with a large central cavity to accommodate dsDNA and lateral holes 
(403). The X-ray studies, however, revealed that the subunits of MCM are ar-
ranged in a dodecamer complex with an unusually long central channel. This 
channel has a large number of positively charged residues that contribute to-
wards DNA binding (404).   
 
 
3.2.4. RNA Helicases, chaperones and match makers 
RNA molecules have an intrinsic tendency to get misfolded and become kinet-
ically trapped. Due to this basic problem, the specific RNA binding proteins 
termed “RNA chaperones,” which can rescue RNA molecules in an ATP-
dependent or independent manner, have been proposed (405–407). The RNA 
chaperones aid with the correct folding of RNA by preventing misfolding or by 
interfering with an incorrect rather than a stable RNA structure (405). For a 
comprehensive classification of the proteins with RNA chaperone activity, 
please see the relevant review (407) and the hyperlink therein.  
In a similar direction, the set of proteins that facilitate the formation of dou-
ble strands as a result of binding to each complimentary strand has been termed 
“match makers.” These molecules often act in an ATP-independent manner. 
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However, in some cases ATP can be used to disrupt the secondary structure of 
RNA; thus, tight regulation and balance between the formation and contortion 
of a duplex exist (405, 406).  
Among all of the SFs, the helicases of SF1 and SF2 are widely considered to 
be helicases that possess RNA chaperone activity and play an important role in 
RNA metabolism (328, 406). It has been proposed that RNA helicase activity is 
a property by which it is possible to estimate the extent to which a protein can 
perform RNA remodeling. These enzymes can unwind RNA via a basic cycle 
that comprises multiple consecutive steps involving ATP hydrolysis or by car-
rying out local strand separation, which requires the binding of ATP but not 
hydrolysis (328, 351). RNA helicases can also displace protein molecules from 
RNA in an ATP-dependent manner (408). However, it is not clear which exact 
functions RNA helicases carry out in a cellular context, where they could be 
involved in regulated interactions with partner proteins to diversify the com-
plexity of their functions by many fold (328).  
 
 
3.2.5. Mechanisms employed by RNA Helicases 
3.2.5.1. Cooperativity, active and passive mode of unwinding 
As mentioned above, the helicases can be divided into two broad categories: 
those that form a ring structure around the NA and those that do not. Ring-shape 
helicases require hexameric structures; for example, in a monomeric state the 
T7 gp4 helicase is not functional. In contrast, for monomeric helicases such as 
NS3, T4 Dda, UvrD, and RecBCD, the formation of oligomers is not necessary, 
although the helicase-related activity of some enzymes could be enhanced with 
the formation of dimers or higher-order oligomers (409, 410). Functional 
cooperation is often attributed to the monomeric helicase; multiple copies of 
these motor molecules are loaded onto the tracking strand, which prevents back 
slippage and enhances the availability of new molecules in case the forward 
molecule falls off (410, 411).  
In a very broad sense, it can be said that helicase can operate in an active or 
a passive manner. In the active mode, the helicase molecule directly unwinds or 
destabilizes the ds NA. Under optimal conditions, an active helicase can unwind 
ds NA as fast as it can translocate onto the NA (412). In case of passive mode, 
the enzyme waits at the ss and ds junction until a thermal fluctuation occurs, 
which opens up the duplex. When this happens, helicase molecules go forward 
to bind to a new junction region, which prevents reannealing.  
 
 
3.2.5.2. Processivity 
It has been proposed that enzymes working on polymeric substrates, e.g., hel-
icases, can carry out multiple rounds of catalysis before dissociating. However, 
the frequency of the dissociation depends on the specific mode employed by the 
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enzyme. In case of binding to the NA, the likeliness of dissociation decides 
whether a particular enzyme is processive or not.  
One group of enzymes, which tends to be not so processive, only partially 
encloses the NA. In contrast, processive enzymes employ their elongated 
asymmetric structures or toroidal symmetry to fully enclose the NA polymer. 
The enzymes with toroidal symmetry tend to be more processive as they do not 
just bind; instead, they gird the NA substrate. However, it should be noted that 
complete enclosure of a substrate is not the only requirement for processivity. 
The specific aa residues that interacts with the NA, as well as the overall con-
formational geometry, must complement the favorable structure of the enzyme 
(380). Alternatively, processivity can also be increased by increasing the sur-
face area of the enzyme that interacts with the NA. Thus, monomeric viral hel-
icases, such as VV NPH II and HCV NS3, are also processive helicases, 
although they do not gird their NA substrates. Instead, they have large surfaces 
to cling to the NA (366, 413). 
 
 
3.2.5.3. Stepping mechanism; Inchworm and Rolling models    
Helicases exhibit directional translocation on their NA substrate. The mecha-
nisms employed by these molecules are poorly understood. The current hypoth-
esis is generally based on changes in enzyme affinity towards NA, which result 
from conformational alterations due to NTP hydrolysis (410). In a proposed 
stepping mechanism, the helicase molecule makes contact at least with two sites 
on the NA, which act accordingly to invoke from NTP hydrolysis. The inch-
worm model in the stepping mechanism assumes that a monomeric helicase 
establishes weak contact and firm contact with the NA. In a cycle of NA adher-
ence, discharge and translocation, the weak bound site decouples due to the so-
called power stroke, moves away from the firmly bound site and establishes 
contact at a new position (410). The rolling model proposed for dimeric helicase 
suggests that the subunit contacts the ssDNA and dsDNA based on the NTP 
hydrolysis state; however, the subunit switches mutually for the leading or lag-
ging position in the translocation process (414).  
 
 
3.2.5.4. Brownian motor model 
The Brownian motor mechanism was originally proposed for HCV NS3. This 
model suggests a two stroke cycle in which the helicase adheres to NA 
alternatively between strong and weak binding modes according to the presence 
or absence of ATP. The absence of ATP results in a directional translocation 
and local melting of basepairs, which is fuelled by energy from ssDNA binding, 
while ATP binding charges the helicase molecule and prepares it for subsequent 
cycles (364, 410, 415).  
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3.2.5.5. Model for non-processive Helicase 
Apart from the above proposed mechanism for processive helicases, there are 
also several mechanisms proposed for non-processive helicase, such as the 
DEAD class of helicase (328, 364). In one of the speculative models, it is pro-
posed that during ATP hydrolysis and release, the helicase adopts a destabiliz-
ing conformation that exposes the electrostatic surface towards the duplex and 
triggers local strand melting. Another model was proposed for the Vasa hel-
icase. It speculates that the helicase can execute force to accommodate only an 
ssRNA while excluding or tearing apart the other strand of the dsRNA substrate 
(328, 364). 
 
 
3.2.6. Role of Helicases in viral lifecycle  
It has been evident that positive strand RNA viruses with genomes larger than 7 
kb and a number of DNA viruses encode for helicases/putative helicases or 
outsource cellular helicases to support their replication cycle. However, the role 
of helicases in the viral replication cycle is still intensely disputed. An immense 
amount of data, originating from biochemical experiments, is poorly aligned 
with the biological data. Thus, interpretations of biochemical evidence to ex-
trapolate biological understanding have been extensively speculative in this 
regard (311, 334, 416, 417). 
Viral infection is responsible for approximately 20% of human cancer cases 
and can cause severe neurological disorders and chronic diseases (418) while 
eighty percent of all viruses are RNA viruses, presumably coding for helicases 
or helicase-related enzymes (334, 417). It should be interpreted in a generic way 
that helicases are important for viruses, and thus it is obvious to predict that 
mutations in potential motifs in the helicase region or the application of com-
pounds targeting these activities could impair viral replication (324, 419). For 
representative purpose I will briefly describe the biological roles of few selected 
viral helicases.  
 
 
3.2.6.1. NS3 Helicase 
HCV NS3 helicase has been extensively studied (358). It belongs to SF2 and 
unwinds both DNA, RNA and hybrid substrates in a 3'-5' directionally biased 
manner (413, 420). The helicase-related activity of NS3 is influenced by the 
presence of a protein cofactor, NS4A (421). Furthermore, alanine scanning of 
the acidic region of NS4A indicates that the NS4A and NS3 interaction is im-
portant for viral replication and particle assembly (422). It has been reported 
that along with a hydrophobic NS4B protein, NS3 physically and functionally 
interacts with HCV RdRp (NS5B). NS3 regulates template recognition by 
NS5B; for this, NTPase and presumably also helicase activities are required. 
The interaction between NS3 and NS5B is negatively regulated by NS4B (423). 
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It has been reported that the proline-rich linker region between the protease and 
helicase portions of NS3 interact with the Src homology 3 (SH3) domain. In-
deed, mutation in the linker region leads to substantial defects in viral replica-
tion and infectivity, which are independent of polyprotein processing and NS3 
stability (424–426). 
 
 
3.2.6.2. Nidovirus Helicase 
Nidovirus helicase, which also possesses RTPase activity, can unwind both 
DNA and RNA substrates in a 5'-3' directional biased manner (427–431). The 
helicase is located at the C-terminal region of nsp13, while the N-terminal re-
gion of the same protein contains ZBD (428). ZBD has been described as 
affecting mRNA synthesis, genome replication, and virion biogenesis (432). In 
the case of SARS-CoV, it has been shown that the RdRp of CoV influences the 
unwinding activity of nsp13 (427), which localizes to the cytoplasm despite its 
affinity towards DNA substrates (429). As it is out of the scope of this thesis, 
the extensive role of Nidovirus helicase in the viral lifecycle may be studied 
elsewhere (430). 
 
 
3.2.6.3. Vaccinia virus Helicase 
DNA viruses such as VV encode for a RNA helicase (NPH II) (417). NPH II 
does, however, unwind both DNA and RNA substrates (433). It has been shown 
that temperature-sensitive mutants of VV, lacking NPH II-related activity such 
as NTPase (and very likely helicase activity as well), fail to produce infectious 
progeny and exhibit defects in transcription initiation (434). This corroborates 
an earlier study that proposed that the DNA helicase activity of the NPH II 
protein is required for the initiation of early transcription (433). The effects of 
alanine mutations that were introduced into the classical helicase motifs of NPH 
II suggest that NTPase and importantly helicase activity of this protein are es-
sential for VV replication (435).  
 
 
3.2.6.4. HIV-associated Helicase  
Retroviruses, including HIV-1, do not encode for a helicase. Instead, these vi-
ruses efficiently outsource a number of host cell helicases for their replication 
process (436). The gene expression of HIV-1 is regulated by interaction be-
tween the virus-encoded Tat and Rev Proteins and host factors, which include 
proteins with helicase-related activities. Rev interacts with pre-spliced mRNA, 
which is transported out of the nucleus to form genomic RNA for packaging. It 
has been reported that cellular helicases, such as DDX1 and DDX3, interact 
with Rev to regulate HIV-1 gene expression during the late stage of viral 
replication. In particular, DDX1 has a functional role in mRNA splicing, 
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transcription and translation (417, 437–439). It has also been reported that many 
other proteins with helicase activity (DHX36, DDX24, DDX17, DHX9, DDX47 
and DDX5) interact with the Rev protein. Of these, DDX5 and DDX17 have 
been shown to affect the production of HIV virions (417, 440). DHX9 is also 
associated with HIV-1 Gag and becomes encapsulated into the virion. HIV-1 
virions, lacking this cellular protein, exhibit reduced reverse transcriptase 
activity (417, 441, 442). It is also reported that the interaction of DDX24 with 
Rev and Gag influences the trafficking of the viral genome for packaging (443). 
 
 
3.2.6.5. Generic role of viral Helicase 
Apart from the above mentioned specific roles of helicases in the life cycle of 
different viruses, few generic functions of helicases have been additionally 
proposed (334, 430). First, it has been observed that helicases are encoded by 
viruses with relatively longer genomes. Therefore, it is suggested that unwind-
ing activity is dispensable for viruses with smaller genomes. Second, as viruses 
with relatively longer genomes encode for helicase, it is possible that helicase 
might be involved in proofreading activity by interacting with polymerases 
(444). This hypothesis is supported by a study examining the fidelity of CHIKV 
replicase with a C483Y mutation in nsP4. It was found that this mutant virus 
acquires a second supportive mutation in nsP2 (G641D), the helicase protein of 
CHIKV. However, the role of nsP2 in the fidelity of CHIKV RNA replication 
still remains unknown (445). In the case of SARS-CoV, another positive strand 
RNA virus, it has been biochemically shown that nsp12, which is the RdRp, 
enhances the unwinding activity of nsp13, the viral helicase (427). Third, as 
suggested for VV, helicases may be involved in RNA-DNA duplex unwinding. 
This places helicase just behind the DNA-dependent RNA polymerase in this 
virus; the aim of this arrangement may be to prevent R loop formation (446). 
Finally, it has been suggested that helicase could play an important role during 
the initiation of translation as deduced from the helicase activity of eukaryotic 
initiation factor 4A-4B (327).  
 
 
3.3. Alphavirus Proteases 
The field of proteases is very extensive and composite. As the current thesis 
reports protease-related activity in the context of CHIKV, it is appropriate to 
briefly review the literature relevant to alphaviral proteases. As alphavirus 
proteases have a crucial role in the maturation of structural and ns proteins, they 
also represent attractive targets for drugs to suppress viral replication (447). 
Indeed, anti-protease compounds are in use in combinational therapy against 
HIV and in recent years also in anti-HCV therapy. This demonstrates how the 
protease enzymes, which are essential for the replication of different viruses, 
can be efficiently targeted (448–450). In the case of alphavirus, the protease 
activity has been reported in two different contexts: first for the capsid auto-
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protease (chymotrypsin-like serine protease) and then for the nsP2 protease 
(papain-like protease) (450–452).  
 
 
3.3.1. Capsid: the autoprotease of alphavirus 
The structural polyprotein of alphaviruses, with a capsid protein region at its N-
terminal portion, is translated from sg RNA (25, 450). The capsid protein 
cleaves itself from this polyprotein and folds into a conformation where its ac-
tive site is blocked (450). In the 264 aa long SINV capsid protein, residues 
H141, N163 and S263 have been identified as a catalytic triad. A recent study 
of CHIKV capsid autoprotease activity revealed that W261, situated at the C-
terminus of this protein, and I227 also contribute to protease activity (453, 454). 
The structures for the capsid proteins of SINV, SFV and Aura virus (AV) are 
informative. In the case of SINV, the residues from 114 to 264 fold into a pat-
tern that resembles the chymotrypsin-like serine protease; furthermore, it is 
evident that residues 261–264 are situated in the active site of the enzyme, thus 
resembling the unprocessed peptide substrate. In particular, a bulky aa such as 
W264 situated at the extreme C-terminus is accommodated back into this cata-
lytic pocket, explaining the auto inhibition mechanism of this protease (153, 
450, 455). Recently, a FRET-based trans protease assay using AV capsid prote-
ase was proposed and used for the screening of inhibitors for alphavirus capsid 
protease (456).  
 
 
3.3.2. NsP2 Protease as a target for potential drug candidates 
As functions of nsP2 have already been discussed extensively in the previous 
section, only its potential use as a drug target is reviewed here. Several research 
studies have attempted to target nsP2 protease activity, which is central for virus 
replication, with small molecules (457–461). After the 3D structure of the prote-
ase portion of nsP2 became available, different techniques were used to predict 
small molecules, which could dock into the proteinase active site (222, 228). 
This resulted in the discovery of different molecules with varying degrees of 
efficiency. It was reported in a non-biologically validated study that Q1039, 
K1045, E1157, G1176, H1222, K1239, S1293, E1296 and M1297 residues of 
CHIKV establish interactions with the peptidase substrate and can be targeted 
with chemical molecules (461). Using a purely bioinformatical platform, a 
ligand that exhibited potential affinity towards the protease domain  has also 
been reported (458). In another study, it was found that thiazolidine derivatives 
could act as CHIKV inhibitors in a low micromolar range; it was proposed that 
these compounds target the protease domain (459). In a comparatively compre-
hensive study, which initially took into account 5 million compounds (for the 
assessment of structure-function relationships), a set of 26 compounds was 
selected for biological validation. In this study, by employing a cytopathic re-
70 
 
duction assay, a compound with relatively higher anti-CHIKV activity was 
described, although its anti-nsP2 activity was not directly demonstrated (457, 
462). As the nsP2 protease is not the only potential drug target for the treatment 
of CHIKV infection, researchers have used diversified approaches to address 
the therapeutic aspects of this highly pathogenic virus. A description of those 
strategies is beyond the scope of the current thesis and can be obtained else-
where (463, 464).   
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4. AIMS OF THE STUDY 
NsP2, a replicase protein of alphavirus, has been the focus of a number of re-
search projects, both in our lab and also around the world. These studies have 
aimed not only to exploit the replicative aspects of this important protein but 
also to assign important enzymatic activities to the various regions of nsP2. 
Furthermore, functions of nsP2 those pertaining to viral replication and/or to its 
catalytic activities have been studied. 
Among its enzymatic activities, the helicase activity of nsP2 has been defi-
ciently studied and understood. It was demonstrated only once, more than 15 
years ago, for nsP2 of SFV (217). Since then, it has not been confirmed for any 
other nsP2s from alphaviruses; in contrast, papers reporting failure to demon-
strate this activity have also been published (209). There have been almost no 
detailed studies to follow up on previous conclusions or more detailed helicase-
related characterizations such as polarity, substrate specificity and other aspects 
has been conducted.   
Helicase is, by definition, quite a straightforward enzyme. In the simplest 
terms, it is an enzyme that catalyzes the unwinding of NA in an NTP hydroly-
sis-dependent manner. Critical observations on this topic led us to imagine that 
the helicase activities of nsP2 ought to be carried out not only by the so-called 
classical domains. So we hypothesized that along with these indispensable clas-
sical helicase-related domains, which coordinate with each other in a productive 
manner, accessory domains may exist as described previously for other bona 
fide helicases. In other words, we expected nsP2 as a helicase to be considera-
bly more complex than the simple so-called “helicase domain protein.” It also 
did not escape our notice that there were increasing amounts of data indicating 
that the “helicase domain” of nsP2 is likely involved in other activities of nsP2, 
such as some of its protease activity as well as the cytotoxic functions of nsP2.  
Thus, the current thesis set out to understand the functional significance of 
various domains of nsP2 by carrying out biochemical experiments. This was 
subsequently extended to experiments aiming to understand how these functions 
are related to the biological properties of virus. The study integrates several 
important aspects of alphavirus biology, making it rather difficult to highlight 
the objectives. Nevertheless the core aims of the thesis can be depicted in the 
following specific or disassembled manner. 
 
I) Elucidate the structural aspects of the full-length nsP2 protein of Chikun-
gunya virus (CHIKV) using a bioinformatical platform and homology 
modeling with special attention to identify the key aa residues that could be 
interacting with NTP molecule.  
II) Standardize a protocol for the overexpression and purification of active 
recombinant nsP2 protein with an authentic N-terminus and various mutant 
versions of the protein with the aim of obtaining appropriate materials for 
biochemical analysis. 
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III) Assess the activity of recombinant protein(s) by employing activity assays 
to examine helicase, NTPase, and protease activities and attempt to opti-
mize the reaction conditions accordingly. 
IV) By employing the knowledge gathered from objectives I, II, and III, try to 
understand the effects of mutations, presumably unrelated to helicase ac-
tivity, such as those in alphaviral noncytotoxic (NCT) mutants in the bio-
chemical protease, helicase and NTPase assays. 
V) Using experience gathered from alphavirus protein overexpression and 
purification experiments, try to purify other replicase proteins of CHIKV 
(and related alphaviruses). This includes the replicase proteins nsP1, nsP3 
and nsP4. Use the recombinant proteins for the production of high-grade 
antibodies that are needed but are unavailable from any commercial source. 
Use these antibodies for studies carried out by our research team as well as 
provide them to other groups working with alphaviruses to contribute to 
the general arena of alphaviral research. 
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5. RESULTS 
The kernels of this thesis have been mostly acquired from the scientific work 
performed for article II, which extensively addresses the purification and bio-
chemical characterization of CHIKV nsP2. This article also set out to demon-
strate the minimal region requirements for helicase activity and requirements 
for optimal NTPase activity, providing further insight into the functioning of 
this protein in an enzymatic context. Finally, this article attempted to standard-
ize the optimal conditions for NTPase and helicase activity with a long term aim 
of proposing or formulating a high-throughput method for screening small mol-
ecule inhibitors to suppress or modulate alphavirus infection as proposed for 
other viruses (465). The core of the results and some data from unpublished 
studies that could have been part of article II (but were not included for several 
reasons) are presented in this section.  
 
 
5.1. CHIKV nsP2 structurally resembles  
the ToMV Helicase (Article II) 
Various research groups around the globe have tried to obtain X-ray crystallo-
graphic structures of full-length nsP2 of alphavirus. Despite significant effort, 
no success has been attained for nsP2 or its N-terminal region. Success has been 
limited to resolving the structure of the truncated version of nsP2, consisting of 
C-terminal domains (protease portion) or these domains together with two 
thirds N- terminal region of nsP3 in a pre-cleavage conformation (222, 228, 
234). Therefore, it was imperative to gather more information regarding the 
structure of full-length and specifically the N-terminal region of nsP2. For 
structural modeling or predicting the key motifs in CHIKV N470 (fragment 
consisting of the first 470 aa of the N-terminal region of nsP2), the sequence of 
this region was processed using various online programs such as PHYRE, 
PHYRE 2, I-TASSER and MODELLER (466–468). All online programs pre-
dicted the structure of N470 to resemble the helicase or NTPase domain of To-
mato Mosaic Virus, ToMV, a member of the alphavirus-like SF of helicases. 
However, the PHYRE server predicted that the structure was comparable to that 
of the Upf1 helicase, which is also a SF1 helicase. In the latter case, the PHYRE 
server took into account only residues from 46 to 444 out of 470 aa residues; in 
contrast, all sequences of N470 (residues 1–470) were accounted for building a 
structure resembling the ToMV helicase (332, 467, 469). It should also be noted 
that the core of ToMV helicase is structurally comparable to the Upf1-like, 
UvrD/Rep and Pif-1-like helicases (469); therefore, the central portions of the 
N470 models based on different structures (ToMV versus Upf1) were relatively 
similar.  
The structure of the modeled CHIKV N470 had three domains: two RecA-
like domains (1A and 2A) and an extreme N-terminal domain (NTD), which 
was predicted to be disordered (Article II, Fig. 1B). Domains 1A and 2A were 
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predicted to be pivotal for NTP binding and hydrolysis (223, 469). The function 
of the alphavirus nsP2 NTD domain has yet to be determined; however, from 
the structural predictions it can be suggested that this region comprising the 
loops may be intrinsically disordered; this region lacks clear structural homol-
ogy with any of the folds in the database, which could indicate that it carries 
unique viral protein folds (470). At the same time, the confidently predicted 
RecA-like fold is omnipresent in the helicase-like enzymes (365). These two 
domains carry the signature motifs for interaction with the NTP molecule and 
its hydrolysis. Thus, it was relatively obvious to conclude that these motifs 
share both functional and sequence similarities with corresponding motifs from 
SF1 helicases such as PcrA, Upf1,ToMV (332, 337, 469). The comparative 
residue profiles of these motifs  are presented as table 2 in article II (215).  
When full-length nsP2 was processed through the above mentioned servers, 
they predicted the structures separately: first, they predicted the structure of 
N470 in reference to the structure of ToMV (469) and then separately processed 
the C-terminal region, affiliating it with the unpublished CHIKV protease 
structure or the VEEV protease structure (222, 228). The limitation with this 
mode of prediction is that it provides no insight into how the N-terminal region 
of nsP2 and its C-terminal region are structurally arranged relative to each 
other. 
 
 
5.2. Expression and Purification of CHIKV nsP4  
(Article I and Unpublished) 
During the studies included in this thesis, a number of recombinant ns proteins 
from different alphaviruses as well as number of other relevant proteins (such as 
TEV protease, HCV NS3 helicase and Ubl-specific protease 1) were success-
fully expressed and purified. To avoid redundancy, only some of the proteins 
that were not reported in the articles are described here. One of these proteins, 
the purification and use of which was essential for publication (Article I), was 
CHIKV nsP4, the alphaviral RdRp. Interestingly, this protein turned out to be 
easy to express but extremely difficult to purify.  
The coding region of nsP4 was codon optimized for a bacterial expression 
system, and the recombinant protein was tagged with a hexahistidine tag at the 
N-terminus. However, repeated attempts to obtain the protein in the soluble 
fraction were unsuccessful. The protein yield was high (which could possibly be 
one factor for insolubility), allowing us to purify the protein from the insoluble 
pellet. This was carried out via collection of the pellet followed by washes with 
PBS and “Triton X-100” containing buffer. The pellet was dissolved in a buffer 
containing 6 M guanidium hydrochloride (to note, the pellet was completely 
insoluble in 8 M urea, a reagent normally used for the purification of insoluble 
proteins). After high speed centrifugation, the obtained supernatant was passed 
through Ni-NTA resin, washed with buffer containing 8 M urea and eluted with 
the same buffer containing imidazole (under these conditions the protein 
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remained in solution). The purified protein was processed further to raise anti-
nsP4 rabbit polyclonal serum that was used to probe the nsP4 in western blot 
experiments (Article I). For individual protein purification purposes, readers are 
advised to peruse the relevant articles associated with the thesis. Of the proteins 
not described in the article, some mutant versions of nsP2 of CHIKV as well as 
nsP1 and the N-terminal portions of the nsP2 and nsP3 proteins of ONNV and 
BFV were obtained, and soluble recombinant proteins were used to raise corre-
sponding antibodies. The technical details of their purification are available 
from the author.   
  
 
5.3. NsP2 is largely an alpha-helical protein (Article II) 
NsP2 and its N-terminal portion have been refractory to attempts for resolving 
their 3D structures. In the absence of a 3D structure, CD spectroscopy is an 
excellent method to estimate the content of the secondary structural elements of 
a protein. It is a quick and straightforward method and is especially useful to 
compare the folding patterns of wt and mutant version(s) of the same protein 
(471). However, it must be considered that the accuracy of secondary structural 
element estimation is highly dependent on the accuracy of the protein concen-
tration (471, 472). For the current study, CD spectroscopic analysis of nsP2 and 
its mutant versions indicated that nsP2 has high alpha helical content. A consid-
erable portion of the protein was indicated to be random coil. These data were 
highly reproducible, indicating that nsP2 is predominately an alpha helical pro-
tein. Furthermore, the protein was also often tolerant to point mutations, for 
example addition and deletion of two aa residues at the N terminus (Article II, 
Fig. 2B) unless they were situated in a sensitive location of this protein such as 
the 5A-PG mutation (Article III, Fig. 6B). In contrast, deletions of the NTD or 
MTL domains resulted in the aggregation of the protein, which was evident 
from size exclusion chromatography and greatly increased CD signal (473). 
 
 
5.4. NsP2 hydrolyzes all canonical NTPs and dNTPs (Article II)  
NTPase activity assays were carried out to exploit the degree of variability be-
tween the wt and the mutant forms of nsP2. In a typical assay, the enzymes 
were treated with high concentrations (relative to the Km) of NTP molecules 
such as GTP (150-200 μM), and their continuous reaction progress was moni-
tored on a spectrophotometer. NTPase activity was strongly affected by the 
presence of a protease domain and the presence of a non-authenticated N-termi-
nus (Article II, Fig. 3D); the defects caused by various NCT mutations were 
smaller and did not correlate with the cytotoxic/non-cytotoxic properties of 
replicons containing corresponding mutations (Article III, Fig. 8A). It could 
also be understood from these experiments that full-length nsP2 was able to 
hydrolyze all canonical NTPs and dNTPs with comparative catalytic rates. 
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GTPase activity was selected to compare the data obtained in the present study 
with that originating from previous works describing the NTPase activity of 
alphaviral nsP2 (209, 210, 220).  
 
 
5.5. NsP2 GTPase activity is moderately stimulated  
by nucleic acid oligomers (Article II) 
The GTPase activity of nsP2 was stimulated by 1.75 μM of NA-oligomers de-
picted in Article II. The degree of stimulation of nsP2 GTPase activity was 
moderate; a maximum effect (stimulation up to 2.5 times above basal activity) 
was observed for polyd(C) (Article II, Fig. 3E). Such an effect is highly compa-
rable to SF1 of helicases such as HEV helicase, TGBp1 helicase, and SFV hel-
icase (220, 474, 475). In contrast, the degree of stimulation is almost residual if 
compared to HCV NS3, which is an SF2 helicase (476). Thus, it could be advo-
cated that the stimulation of NTPase activity by NA-oligomers may be an ex-
pected characteristic of nsP2 but may not be a compulsory (or prominent) at-
tribute. 
 
 
5.6. NsP2 is a 5'-3' RNA Helicase (Article II) 
Historically (or to provide the enzyme with the most conducive substrate), hel-
icases have been mostly studied using artificial substrates to determine direc-
tionality, substrate specificity and possible occlusion size. In some cases, bio-
logically relevant substrates have also been studied (326, 420, 477). As the 
biologically relevant substrate for nsP2 is not known (as the role of helicase 
activity of nsP2 in the virus life cycle is not clear), the substrates used in the 
current study were adapted from studies dedicated to the analysis of HEV hel-
icase activity (474). The treatment of appropriate dsNA substrates with nsP2 
and its mutant forms in the presence of ATP demonstrated that nsP2 works as a 
helicase on the RNA substrate in a 5'-3' directionally biased manner. The occlu-
sion size of this enzyme could be predicted to be in between 7 to 12 nts. This 
enzyme remained unresponsive to DNA substrates with equivalent properties 
(Article II, Fig. 4).  
 
 
5.7. NsP2 also unwinds hybrid substrates (Unpublished) 
When a hybrid substrate comprising a RNA tracking (longer) strand of 28 nts 
and a DNA displacing (shorter) strand of 16 nts was presented to CHIKV nsP2, 
it exhibited quite evident unwinding activity (Fig. 22). When a substrate con-
taining longer DNA and shorter RNA strand was presented, the outcome was 
inconclusive: a certain amount of displaced ss strand was also observed in the 
absence of ATP (Fig. 22).  
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Figure 22. CHIKV nsP2 unwinds both dsRNA and hybrid RNA:DNA substrates where 
the tracking strand is RNA. In an alternative situation where DNA is used as the track-
ing strand, a reproducible ATP-independent release of ssRNA was observed. Most 
likely this could be attributed to the instability of this particular type of hybrid substrate. 
 
 
It should be noted here that thermodynamically the hybrid substrates such used 
in this study are less stable than their homogenous counterparts (478). Thus, 
passive mode of helix destabilization may also take place. Such activity is also 
observed for the nsp2C of Picorna-like virus, in which the RNA chaperone-like 
activity can be functionally separated from its ATP hydrolyzing activity (479). 
At this point we cannot rule out that the same could be true for the last substrate 
with longer DNA and shorter RNA strand. Indeed, it remains possible that un-
der the tested conditions this particular substrate becomes intrinsically unstable 
or a passive way of hybrid substrate unwinding could occur. To provide a de-
finitive answer, the ability of nsP2 to unwind such a substrate must be carefully 
investigated using a panel of control substrates before conclusions are drawn. 
 
 
5.8. NsP2 possesses RNA annealing  
or matchmaker activity (Article II) 
Rewinding activity is opposite to the unwinding activity, which means that the 
enzyme can supposedly anneal complementary ssRNA strands to form dsRNA. 
It was suspected that the RNA annealing properties of nsP2 may be the reason 
for its low helicase reaction processivity as well as productivity. To verify this 
hypothesis, the enzyme was mixed with ssRNAs that were complementary to 
each other, and the reaction was carried out under conditions that were non-
optimal for helicase activity: the salt concentration was kept minimal (1 mM) 
and ATP was not added. It was indeed observed that under these conditions 
nsP2 works as an RNA strand annealer for the substrates, purportedly forming a 
fork-like structure (Article II, Fig. 6 C). The enzyme was less effective with 
substrates supposedly forming 5' overhang products (Article II, Fig. 6 A, B), 
possibly because binding of nsP2 to a shorter ssRNA strand hampered duplex 
formation. Interestingly, nsP2 with an N-terminal His-tag was a more efficient 
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annealer than nsP2 with an authentic N-terminus (Article II, Fig. 6). The ob-
tained results are quite consistent with previous observations with the Ded1 
helicase (350). The RNA annealing process is presumably facilitated by the 
binding of nsP2 to an individual RNA or both RNA strands, which increases 
their probability of being in close proximity to each other, thereby enhancing 
macromolecular crowding and the rate of annealing (407). 
 
 
5.9. Reaction parameters residually influence  
nsP2 unwinding activity (Article II) 
Enzyme reactions are very often influenced by the parameters by which they are 
driven. In case of the nsP2 helicase assay, the reaction criteria such as time 
kinetics, enzyme concentration, monovalent salt concentration, pH, nucleotides 
and temperature were varied, and the effects of these variables on the reaction 
were observed. It was noticed that the products of nsP2 helicase activity can be 
detected at very early time points and that reactions (in approximately 30 min) 
reach equilibrium irrespective of the type of substrate. The considerable in-
crease in the enzyme concentration with respect to the substrate could not make 
the helicase reaction more productive. These data are consistent with idea that 
nsP2 as a helicase is an enzyme with moderate processivity. In turn, it implies 
that the enzyme is unlikely to be involved in unwinding long dsRNA duplexes 
such as replication intermediates of CHIKV (which have length of approxi-
mately 12 kbp). It was also observed that the presence of an N-terminal His-tag 
decreased the reaction amplitude; most likely this was due to the enhanced abil-
ity of this enzyme to catalyze the backward (rewinding) reaction (Article II, Fig. 
5 A, B), although a defect in RNA unwinding (for example due to compromised 
NTPase activity) cannot also be ruled out.  
Other reaction parameters, such as those referred to in the published paper 
(Article II, Fig. 7), did not have notable effects. NsP2 helicase activity was 
observed to be very sensitive to elevated salt concentrations (Article II, Fig. 
7A). The least preferred nucleotides hydrolyzed to fuel unwinding activity were 
UTP and dGTP (Article II, Fig. 7C), and the enzyme preferred Mg divalent 
cations over the others tested (Article II, Fig. 7D). 
 
 
5.10. N-terminus of CHIKV nsP2 is important for  
2/3 site processing (Unpublished) 
The N-terminus of nsP2 was clearly important for NTPase activity and its in-
tactness also affected helicase activity (Article II). In the case of nsP2 of SFV, it 
affects the protease activity, more specifically the ability to cleave the 2/3 site. 
To verify that this was also the case for nsP2 of CHIKV, wt nsP2 was used to 
process substrates corresponding to the 1/2 site, 2/3 site and 3/4 site (the design 
of these substrates are described in Article III). In addition, variants of nsP2 
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containing minimal alterations in the N-terminal region were assayed for their 
ability to process the 2/3 site.  
As expected, nsP2 efficiently processed substrates corresponding to the 1/2 
and 3/4 sites. The 2/3 site in its short form was processed very inefficiently (if 
at all); however, a longer substrate corresponding to this site was efficiently 
cleaved (Fig. 23). Thus, the basic requirements for protease substrates were 
similar or comparable to those revealed for nsP2 of SFV (132). NsP2 lacking 
just two N-terminal aa residues was not able to cleave the 2/3 substrate (Fig. 
23). In contrast, the addition of two extra aa residues to the N-terminus did not 
affect the ability of the enzyme to cleave this substrate (Fig. 23), indicating that 
nsP2 of CHIKV tolerates the addition of extra aa residues in this region. Based 
on this property, nsP2 of CHIKV is different from nsP2 of SFV as in the latter 
case both deletion and insertion of just a single aa residue has a detrimental 
effect on the ability of nsP2 to process the 2/3 site (132). It should be noted that 
the 2/3 site of CHIKV has a much more favorable aa sequence for cleavage than 
the corresponding site in SFV nsP1234. Thus, it is possible that better context of 
the cleavage site made the enzyme more tolerant to some modifications at its N-
terminus. Most likely it indicates that nsP2 of CHIKV can, at least to some 
extent, cleave the 2/3 site in the nsP123 polyprotein before its N-terminus is 
liberated by the cleavage of the 1/2 site. Indeed, evidence of this cleavage has 
been observed in in vitro translation experiments (our unpublished data). 
 
 
 
Figure 23. Processing of the 2/3 site from the CHIKV nsP1234 site is sensitive to ma-
nipulations of the N-terminal region of nsP2. Left panel: nsP2 is able to process sub-
strates containing short variants of the 1/2 and 3/4 cleavage sites but not similar sub-
strates corresponding to the 2/3 site. Right: substrate containing a longer version of the 
2/3 site is cleaved by wt nsP2 but not with nsP2 lacking 2 aa residues in its N-terminus. 
Please see text for more details. 
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5.11. N- and C-terminal domains of nsP2 may interact  
with each other (Unpublished) 
It was ascertained during the purification process of various versions of nsP2 
that a hexahistidine tag followed by a TEV protease site could not be removed 
from full-length protein using TEV protease.  
 
 
 
Figure 24. Accessibility of the TEV protease cleavage site for the TEV protease. Re-
combinant proteins were treated with TEV protease and attempted to bind to Ni-NTA 
resin. TEV protease-treated nsP2-delNTD (#) and nsP2-delMTL (¤) failed to bind the 
resin, indicating the removal of the tag. In contrast, His-nsP2 (*) bound the resin effi-
ciently and was eluted from it only in the presence of imidazole. 
 
 
In contrast, an identically placed tag was easily removed from N470, which 
lacks the last two C-terminal domains (protease and MTL). This finding pro-
voked the idea that these two domains (or one of them) impose steric hindrance 
on the TEV protease to process its site at the extreme N-terminus of nsP2 (Arti-
cle II). To test this possibility, recombinant proteins lacking either NTD or the 
MTL domain were constructed and expressed. It was found that an N-terminal 
hexahistidine tag was efficiently removed from both of these truncated proteins 
using TEV protease (Fig. 24). In the case of a deleted version of NTD, it could 
be proposed that the N-terminus of the protein fell short of reaching the cavity 
between the protease and the MTL. Interestingly, in the protein lacking MTL 
domain, the deletion apparently exposed that cavity, making the tag accessible 
for TEV cleavage. This observation is critically referred to in article II; how-
ever, data affiliated with this thesis was not presented there. 
The article III associated with this thesis addresses the characterization of 
NCT mutants of CHIKV obtained in cell culture selection experiments. 
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Relevant to this thesis is the part involving the characterization of nsP2 proteins 
carrying mutations identified in these replicons. The screening resulted in sev-
eral mutations and biological assays confirmed that mutations critical to the 
NCT phenotype are located in nsP2. Interestingly, however, these mutations did 
not affect the localization of nsP2 in infected cells, indicating that these muta-
tions affect certain other functions of nsP2 rather than its subcellular localiza-
tion. It was found that NCT-related mutations invariably affect almost all en-
zymatic activity of nsP2 including protease, NTPase and helicase activities. It 
was proposed that defects in one (or several) of these activities are crucial for 
the NCT phenotype of corresponding replicons. 
 
 
5.12. Protease activity is selectively affected  
by NCT mutants (Article III) 
The protease substrates, corresponding to various cleavage sites, were presented 
to CHIKV wt nsP2 and to enzymes carrying various NCT-related mutants. It 
was observed that the mutation 5A (insertion of five aa between 647–648 resi-
due) (Article III) had a mild effect on the protease activity of nsP2. In contrast, 
the PG (P718G) mutation alone or in combination with other tested mutations 
compromised proteolytic activity towards the 1/2 and 3/4 cleavage sites (Article 
III, Fig. 7B). None of these mutations compromised cleavage of the 2/3 site in 
its longer version (Article III, Fig. 7C). These data suggest that NCT-related 
mutations, especially the PG mutation, slow down the processing of 1/2 and 3/4 
cleavages. This effect was, however, not observed in the context of infectious 
viruses, indicating that cleavage of the same site in infected cells was affected 
to a much lesser extent; a hypothesis explaining this discrepancy is provided in 
Article III. 
 
 
5.13. NCT mutants affect GTPase activity as well as often abolish  
the stimulatory effects of RNA oligomers (Article III) 
The PG (P718G) mutation reduced GTPase activity relative to nsP2 to a consid-
erable degree; the effect was greater for the combination of EK-PG (E117K and 
P718G) mutations but smaller for 5A-PG (insertion of five aa residue between 
647–648 and P718G). As both of these combinations result in an NCT pheno-
type for the corresponding replicon, there was no clear correlation observed 
between the degree of GTPase activity reduction and the phenotype of the repli-
con. When the GTPase activity was stimulated by the addition of poly(U), it 
was observed that wt nsP2 and nsP2-5A were stimulated. NsP2-PG and all pro-
teins with double mutations, except nsP2-EK-PG, remained insensitive to the 
addition of poly(U). Again, as nsP2 EK-PG (non-cytotoxic combination) was 
efficiently stimulated by poly(U), no clear correlation between the effects of the 
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oligonucleotide on GTPase activity and the phenotype of the replicon was ob-
served (Article III, Fig. 8 A, B). 
 
 
5.14. Amplitude of RNA unwinding is reduced by  
NCT-related mutants (Article III) 
NsP2 has been demonstrated to unwind RNA molecules with 5' overhangs. It 
was shown that the helicase activity of nsP2 is also reduced by mutations origi-
nating from NCT replicons. Due to the nature of the experimental quantitation, 
the effects of mutations on nsP2 helicase activity were relatively inaccurate; no 
statistically significant data were obtained. Nevertheless, helicase activity was 
the only activity of nsP2 for which a correlation between the NCT phenotype 
and a functional defect in nsP2 was observed: helicase activity was lowest in the 
case of nsP2 with 5A-PG or EK-PG mutations (both of these combinations were 
found to cause the NCT phenotype) (Article III, Fig. 8 C, D). 
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6. DISCUSSION 
6.1. Structurally and functionally, nsP2  
could be much more composite  
As it is understood now, nsP2 consists of five domains (Article II). It is a com-
plex protein, and our understanding of its functions is therefore complicated as 
well. For example, nsP2 currently has been reported to possess four enzymatic 
activities, of which NTPase and RTPase are assigned to the N-terminal region 
and protease is ascribed to the C-terminal region. However, to what region does 
the helicase activity belong? Only full length nsP2 has the capacity for RNA 
unwinding activity, indicating that apart from canonical RecA-like domains, the 
extreme C-terminal portion of the protein (MTL domain), and most likely the 
NTD, are involved, but the question is how? An obvious guess is NA binding. 
This hypothesis is supported by various practical observations. Specifically, 
during the purification process for the SINV P23Pro-Zbd, it was noticed that a 
considerable amount of bacterial RNA was intrinsically bound to the allegedly 
purified protein (234). Thus, MTL along with the ZBD likely provides a RNA 
binding platform that regulates the functionalities of nsP2, such as the protease 
activity of the enzyme (480). However, it remains unexplained whether the 
same could also affect helicase functionalities. It was shown in Article II that 
full-length nsP2 is sufficient for RNA unwinding. However, if a stretch of nsP3 
reaching up to the ZBD was included; would the enzyme become more proces-
sive? This outcome seems feasible, as an additional RNA binding platform may 
indeed increase the processivity of the helicase enzyme. However, just as easily, 
a similar addition may also render the nsP2 selectively nonfunctional, for ex-
ample by affecting NTPase activity. Furthermore, NA binding activity is not the 
only function that could be attributed to the NTD and MTL domains. For exam-
ple, these domains could function by structurally stabilizing the rest of the nsP2 
(131, 209, 220, 222). 
NsP2 possesses an abnormally long linker region (~30 aa); an average linker 
size is approximately 10 aa, but a large linker can be as long as 28 aa (228, 481) 
between the protease and MTL domains. Why a multitasking protein such as 
nsP2 should carry such a long stretch of inter-domain loop is unclear. Is it 
reaching out to something or is it ensuring the MTL has relative flexibility and 
larger domain motions than the other domains? It is possible (as discussed in 
Article II) that a positively charged domain such as MTL could provide an RNA 
binding platform. If so, it may need such a type of loop to cling on to the RNA, 
which somehow necessitates greater motion. Previous studies with SF2 viral 
helicases such as NS3 from HCV, DENV, and WEEV have shown that the full-
length enzyme harboring the protease domain influences the unwinding activity 
of the helicase domain, most likely by increasing RNA binding activity (360, 
361, 482). The data obtained by manipulating the linker region of DENV NS3 
suggest that both the helicase domain and protease domain not only must be 
present on the same polypeptide but also must rotate in a controlled manner 
84 
 
through the linker region, for which unnecessary flexibility would be counter-
productive (363). As alphavirus nsP2 is a multidomain protein, it is likely that a 
long linker could also be involved in performing equivalent functions. Clearly, 
further investigation beyond its previously described role in minus strand syn-
thesis (230) of the linker region in nsP2 is necessary.   
 
 
6.2. The N-terminal domain of nsP2 implements diversified functions  
To date, the 3D structure of the NTD of nsP2 remains unresolved. Homology 
modeling software programs predict it to be “partially disordered,” but it is 
highly unlikely that such a long portion of the protein could indeed lack a de-
finitive structure. Instead, it is conceivable that some part of this stretch is 
structurally disordered. The secondary structure prediction server forecasts with 
a reasonable degree of confidence that the NTD contains both β-strand and α-
helices with a considerable amount of loops as well (483). Thus, it is very likely 
that this region is at least partly disordered. Viral proteins are indeed abundant 
sources for this type of intrinsically disordered region, which assists them with 
adapting to rapidly changing environments by replenishing interactions with 
proteins and NA molecules (484, 485). In line with this view, it has been pro-
posed that the N-terminal region of nsP2 acts as a cofactor for protease activity 
and is involved in interactions with the 5' end of the viral genome (131, 486). 
Later studies have clearly shown that the exactness of the N-terminal region 
(length and accurate aa sequence of the N-terminal portion of nsP2) is pivotal 
for cleavage of the 2/3 site. This process is driven by fine-tuned interactions 
between this particular domain and the MD of nsP3 (132). Taken together, it 
could be concluded that the existing evidence supports the notion that NTD 
(and its N-terminus) is designed for a number of complex functionalities. Thus, 
it is quite possible that this region could not only be disordered but may also be 
unique, as it has evolved to support functional diversification.  
 
 
6.3. The authenticity of the N-terminus is 
 important for nsP2-related activities 
Consistent with previous studies from our research group (132), the studies 
presented in this thesis confirm that the N-terminus is important for several 
enzymatic functions of nsP2 (Article II and unpublished studies). These obser-
vations reinforce previous findings and extend them to functions other than 
alphaviral nsP2/3 site cleavage. Thus, His-tagged nsP2 demonstrated reduced 
NTPase and helicase activity and enhanced RNA annealing activity. It may 
sound obvious to expect that a positively charged tag (such as a hexahistidine 
tag) should enhance RNA annealing by increasing macromolecular crowding 
(407). However, it is less obvious and remains undefined how such a small N-
terminal tag affects NTPase and RNA helicase activities as well.  
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It was observed that nsP2 itself could cis cleave a His-tag from its N-termi-
nus quite efficiently (assuming there is a suitable cleavage site). The same re-
gion was apparently not accessible for trans cleavage by the TEV protease 
(Article II and see the results section). Most probably, it indicates that a foreign 
cleavage site strained the protease active center and trapped the nsP2 in a “pre-
cleavage” conformation. In turn, this prevented optimal domain coordination 
needed for maximal enzymatic activities, hence a reduction in NTPase activity.  
The strict requirement for a native N-terminus complicates the expression of 
functional proteins, as N-terminal tags are clearly unfavorable. The problem can 
be circumvented by a His-tag at the C-terminus of nsP2; however, it is still not 
the solution as an initiation codon-derived extra Met residue will be placed at 
the N-terminus of the protein (the native N-terminal residue of nsP2 is Gly). It 
was already demonstrated that for SFV, the addition of just one simple unnatu-
ral aa is unfavorable for nsP2 to process the nsP2/3 site (132). There may be 
fewer problems for nsP2 of CHIKV, as the cleavage of the P2/3 site was more 
tolerant to small extensions at the N-terminus (Fig. 23) than to deletions. How-
ever, NTPase activity was still uniformly and significantly reduced by N-termi-
nal manipulations (Article II). Thus, researchers should be cautious while using 
N-terminally tagged nsP2 in any study, as claiming that “such a small tag is 
unlikely to affect the function of the protein” is not true. The same applies for 
other alphaviral ns proteins as well. The genuineness of the N-terminus is im-
portant for nsP4, as substitution of an authentic N-terminal Tyr residue in nsP4, 
the RdRp of alphavirus, with any non-aromatic aa residue is fatal; even the 
addition of a single extra Met residue to its native N-terminus strongly affected 
the ability of SINV to replicate (270). Furthermore, similar examples are known 
for other viral proteins. For example, helicase-related functions of SARS-CoV 
nsp13 (or its homolog from HCoV 229E) are also sensitive to tags such as hex-
ahistidine, glutathione S-transferase and maltose binding protein. Furthermore, 
even the way in which the recombinant protein is overexpressed affects its 
functions (430). In the case of nsp8 (~22 kDa), the second ns protein carrying 
RdRp activity in addition to nsp12 (~106 kDa), the main polymerase of corona-
virus, it was observed that adding a His or ubiquitin tag at the N-terminus of 
this relatively small protein affects its ability to perform synthesis of oligonu-
cleotides. More specifically, a His-tagged nsp8 was able to synthesize only very 
small (< 6 nt) oligomers; in contrast, non-tagged (or C-terminally tagged) nsp8 
synthesized much longer products. This finding suggests that the N-terminal 
fusion partner affects the polymerization capability of nsp8 (487–489). One 
reason for these effects may be that the presence of an extra tag at the N-termi-
nus may mimic the situation prior to the liberation of the N-terminus of the 
protein via protease cleavage. If so, the properties of the tagged proteins, may 
resemble those of proteins still incorporated with its polyprotein precursor. 
Unfortunately, extrapolating the attachment of a fusion partner for viral en-
zymes to the presence of viral protein at the same position before polyprotein 
cleavage has little support. Thus, the 3D polymerase of poliovirus is inactive as 
long as it is attached to the 3C protease; in contrast, the unprocessed polyprotein 
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(nsp7-nsp8-His) of SARS-CoV extends the primer with an efficiency compara-
ble to that of nsP7+nsP8-His (both proteins present as individual subunits) (489, 
490). Taken together, to determine the dependable functionalities of any patho-
gen-related enzyme, the recombinant proteins must be as comparable to their 
natural counterparts as possible. 
 
 
6.4. The Overlaps: NTPase, RTPase and Helicase 
Viral helicases such as alphavirus nsP2 are among the insufficiently studied 
enzymes. In a way, this reflects underestimation of the extent or magnitude to 
which the virus replication process could be dependent on these enzymes. The 
viral RNA helicases or the motifs involved in the process have diversified func-
tions to carry out, such as NTPase, RTPase and helicase (209, 210, 474, 491, 
492), but all of these reactions are executed or fuelled from a common reaction 
center comprising the signature motifs (225, 316, 493). Thus, it is exceedingly 
difficult to dissect these functions from each other and very complex to under-
stand which activities are performed at which stages of the replication cycle (or 
if they could happen simultaneously) as well as which of them (or all of them) 
is critically important. Until now, attempts to analyze this state of affairs have 
been carried out by putting point mutations in the Walker A or Walker B motifs 
(213, 226). This is not truly informative; as such mutations silence all three 
activities of the protein. Thus, caution should be maintained when elucidating 
the interpretation of these ad hoc data, and one of the immediate goals could be 
to identify key aa residues on nsP2 that can affect RNA unwinding activity but 
no other activities of this protein. This will allow experiments to be carried out 
on a completely different level and potentially reveal the true significance of 
RNA helicase activity for alphaviruses. 
 
 
6.5. N- and C-terminal domains of nsP2  
contribute to Helicase functionality 
Alphaviral nsP2 terminal domains are investigated to be of considerable signifi-
cance in many ways however they exhibit a number of contrasting characteris-
tics. The N-terminal domain is predicted to be disordered (Article II), while the 
C-terminal MTL domain is folded, and its structure (resembles Ftsj MTL  
domain) has been resolved (222). TEV protease cleavage accessibility data pro-
vide indirect evidence that these two domains interact with each other (Fig. 24). 
This hypothesis is further supported by the difference in the electrostatic poten-
tial of these domains: the calculated pI of the NTD is ~5.4, while the pI of MTL 
is ~10.13, resulting in an electrostatic interaction between these terminal 
domains (Fig. 25). It was also found that a manipulated version of nsP2, such as 
Hel470, or other truncated versions of nsP2 (Article II) or fragments of nsP2  
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(aa residues 167-630) tagged with maltose binding protein all lack helicase 
activity and possess compromised NTPase activity (209).  
 
 
 
 
Figure 25. Electrostatic surface of CHIKV nsP2 showing the overall charge distribution 
across various domains. Note that the NTD (N-terminal domain) is highly acidic (pI 
5.4), while the C-terminal MTL domain is highly basic (pI 10.13). Please refer to the 
text for more detail (Article II and (228)).  
 
 
It is straightforward to anticipate that basic MTL serves as a binding platform 
for NA. It is much harder to imagine how the acidic NTD domain contributes to 
RNA unwinding. For this, some existing data can provide help. It has been 
previously suggested that the NTD domain of VEEV can interact with RNA. 
Thus, despite its generally acidic nature, some exposed positively charged (15% 
of 170 N-terminal aa) residues could be sufficient to catch onto the RNA (486). 
It has been proposed that for an acidic enzyme such as the helicase domain of 
NS3 (pI~6), a relatively low pH such as 6.5 considerably activates RNA un-
winding, presumably by deprotonating the acidic side chain; this generates a 
selective and regulated repulsive force for processive translocation along the 
NA (494). However, it is unclear to what extent this hypothesis holds true for 
CHIKV nsP2. As for now, we only know that a hexahistidine tag (a highly pos-
itively charged patch of aa) attached to this region reduced RNA unwinding 
activity. This may occur by imposing unfavorable positive charges in a nega-
tively charged domain (Article II). Certainly, the role of the acidic N-terminal 
domain demands further insightful studies. 
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6.6. Stimulation of NTPase activity by nucleic acid  
oligomers may not be a compulsion 
Helicase activity is fuelled by the NTPase activity of the same enzyme. There-
fore, it is obvious that these two biochemical reactions are coupled. In this line 
of thought, there is a broad consensus around helicase research community 
regarding the stimulation of NTPase activity by NA-oligomers; in some cases 
the effects of stimulation are more than 15-fold. The effects of NA on NTPase 
activity could thus be correlated to helicase activity. However, this may not be 
universal for all helicases. To support this assumption, I reviewed the above 
mentioned properties for a number of helicases studied over the years. It has 
been observed that the helicases, which exclusively unwind RNA substrates, 
may not exhibit more than a 2- to 3-fold NTPase stimulation by NA-oligomers 
as exemplified by helicases from SFV, TGBp1 plant virus, CHIKV, Hepatitis E 
virus, turnip yellow mosaic virus, rubella virus, and plum pox potyvirus, which 
all belong to SF1 (209, 220, 474, 475, 495–497). On the other hand, those hel-
icases that unwind both RNA and DNA substrates may exhibit more than 10-
fold NTPase stimulation by NA-oligomers as exemplified by helicases from 
HCV NS3, DENV NS3, WNV NS3, Hepatitis G Virus, YFV, SARS-CoV(SF1), 
and UPF1(SF1) (476, 498–503). However, there are also exceptions. The 
NTPase activity of the VV RNA helicase NPH II is 40-fold stimulated by NA-
oligomers despite the fact that the enzyme also has high basal activity 
(9600/min) (504). This may be because this helicase was also shown to unwind 
DNA:RNA hybrid substrates with an unusual bias towards purine-rich se-
quences (505). Combined, these data raise an important issue of how the first 
category of molecular motors could be unwinding the RNA. Low NA stimula-
tion makes the use of an HCV NS3-type model (the Brownian model that sug-
gests that ATP hydrolysis acts as a molecular switch in between high and low 
affinity DNA binding states (415)) unlikely. Thus, it is likely that exclusive 
RNA helicases all together should possess a different mechanism for how they 
interact and translocate on RNA; it is likely that their apparently unprocessive 
nature is related to this mechanism. This speculation is supported by the fact 
that while HCV NS3 mostly interact with the phosphodiester backbone (372) 
and thus does not discriminate between RNA and DNA substrates, exclusive 
RNA helicases should interact in a unique way that allows them to authenticate 
their NA substrate. These scientific contemplations clearly require further ex-
perimental support; it would be essential to reveal with what part(s) of their 
substrates these enzymes interact. 
 
 
6.7. Could there be any biological significance  
to nsP2 Helicase directionality? 
NsP2 of CHIKV demonstrates 5'-3' RNA unwinding activity. However, is there 
any biological relevance to this directionality or this is just an intrinsic and 
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biologically disconnected ability of most helicases? Currently, the viral helicase 
community has only been able to put forward very speculative models that pro-
pose that directionality may originate from interactions between viral RNA 
polymerases and helicases (67, 427, 430). However, the theory regarding poly-
merase and helicase interactions in the context of alphavirus RNA replication is 
still very premature and is supported only by limited indirect evidence. Alpha-
virus RNA polymerase polymerizes nascent RNA in a 5'-3' direction; to do so, it 
must translocate on the template strand in a 3'-5' direction (268). Thus, if the 
alphavirus nsP2 helicase had to use the same strand, then there would be a colli-
sion between these two oppositely translocating enzymes. Furthermore, it seems 
highly improbable that the synthesis of a positive strand is carried out from a 
naked negative strand; instead, the templates for new positive strands are 
dsRNA replication intermediates (66, 67, 146, 506). It is, however, unclear 
whether alphavirus RNA replication occurs in a conservative (displacement of 
nascent strand) or semiconservative (displacement of the old positive strand) 
manner (67). In any case, however, it appears likely that the RNA polymerases 
and helicases of positive strand RNA viruses work together. Indeed, the helicase 
and the polymerase not only interact but also influence each other’s compli-
mentary functions (507–511). Thus, it is reasonable to expect that nsP4 RNA 
polymerase and nsP2 helicase could work together on viral dsRNA intermedi-
ates. If so, they translocate on opposite strands but work towards a common 
goal of synthesizing and displacing a positive strand. Detailed studies are 
needed to reveal exactly where and how RNA unwinding and/or RNA rewind-
ing activities of nsP2 are utilized. 
 
 
6.8. NsP2-related enzymatic activities are  
affected by NCT-associated mutations 
In article III, it has been shown that NCT-associated mutations reduce CHIKV 
nsP2-related functionalities. This is the first study in which such a link has been 
clearly demonstrated. Nevertheless, it is still vague as to whether CHIKV-in-
duced cytotoxicity is reduced directly due to a decrease in nsP2 enzymatic ac-
tivities and/or, because the corresponding mutations also negatively affect RNA 
replication subsequently reducing the concentration of nsP2 in infected cells. As 
these effects are linked to each other, the entire puzzle is difficult to unravel. 
It should also be mentioned that the P718G mutation (originally obtained in 
studies using SINV replicons) alone is not sufficient for the NCT phenotype in 
the case of CHIKV replicons. It does, however, serve as an initial starting point 
for selection to find other related mutations (235, 293). This raises a question: 
why are secondary mutations needed? It can be observed that the P718G muta-
tion alone results in a decrease in all nsP2 enzymatic activities, and additional 
mutations such as 5A and EK do not result in significant additional decrease in 
these nsP2 activities. In contrast, 5A mutations actually increased the NTPase 
activity of nsP2-PG while EK restored oligonucleotide stimulation of nsP2- PG 
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(Article II). Taken together these data suggest that the appearance of the NCT 
phenotype does not exclusively result from a reduction in enzymatic activities. 
These additional mutations could, at least in the case of CHIKV, underlie 
among other activities of nsP2. One speculative hypothesis could be that these 
mutations somehow affect the assembly of optimal replication complexes by 
altering fine-tuned interactions between various ns proteins. Most probably, 
these mutations, such as 5A-PG, could render the structure of nsP2, which is 
cardinal to the regulation of alphavirus replication, overly flexible. Such 
changes might disrupt certain essential interactions, resulting in suboptimal 
replication machinery and compromised synthesis of all virus-related compo-
nents (proteins, RNAs). It remains to be investigated what other viral activities 
and/or, more importantly, the sequence in which they are affected or must be 
affected during the process leading to the NCT phenotype. 
 
 
6.9. Quality and purity of recombinant protein  
is a key to effective antigenicity 
During this study, a number of ns proteins from different alphaviruses (CHIKV, 
ONNV, and BFV) were expressed and purified. The main objective of this part 
of the study was to obtain materials needed for the immunization of rabbits (or, 
in one case, also chickens) to raise polyclonal antisera. It is possible that ad-
vanced peptide synthesis would allow avoiding such an “old-fashioned” ap-
proach. However, to the best of our knowledge, none of research teams who 
have attempted to use this approach (of which there were at least several) have 
been able to obtain antibodies of comparable quality; in many cases, the antisera 
obtained failed to recognize the viral proteins at all. 
The expression of recombinant proteins could also be considered trivial, and 
as far as the mere yield of recombinant protein is concerned, it is indeed so. The 
problem is to obtain protein in its native (and most immunogenic) form. It 
should be noted that there is no universal purification protocol applicable for all 
proteins; in contrast, individual protocols (or variations of existing protocols) 
were developed for each and every one. Even then, the quality of proteins re-
mained variable. In retrospect, it could be clearly observed that the purity as 
well as the nativeness and solubility of a protein are crucial for antibody pro-
duction. Thus, CHIKV nsP4 was largely insoluble and despite the high amounts 
and purity of the antigen, the obtained antisera were of the lowest quality (com-
pared to others): they were suitable for western blot (Article I) and immunopre-
cipitation but not effective enough for making high-quality immunofluores-
cence images. In contrast, Hel470 is soluble and native protein and the polyclo-
nal serum that resulted from using this protein work perfectly both with western 
blotting and immunofluorescence staining (Article III). These observations, 
although they may appear somewhat trivial, reinforce the notion that for good 
quality antibody production, pure and native high quality protein antigen is 
necessary. 
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7. CONCLUSIONS  
Alphavirus enzymology and biochemistry has long history. Several important 
findings in this area date back to the time when the technology of protein ex-
pression and purification was still in a very early stage of development. So it 
was both of utmost curiosity and importance to re-evaluate the conclusions 
drawn in the previous studies of different alphaviruses using the most medically 
important member of this group – CHIKV – as research entity. Similarly, it was 
necessary to attempt to amend our current understandings with new experi-
mental evidence. So this study was carried out to provide in-depth biochemical 
analysis of nsP2 – convincingly the most complex of alphavirus proteins –  
using controlled and high quality wt full length protein as well as its variants 
harboring various point mutations obtained from biological studies. Similarly, 
various truncated forms of this protein, designed according to previous exten-
sive works corroborating nsP2 and its functions, were prepared, purified and 
analyzed. In this study I not only examined almost all the enzymatic activity 
related to nsP2 but also produced recombinant proteins as valuable tools to 
study different aspect of alphavirology. This allowed, to some extent, connect-
ing biochemical properties of nsP2 to biological properties of the corresponding 
virus and its mutants. Thus, in its final form this study could be clearly differ-
entiated into two broader parts. The first part extensively addresses the basic 
biochemistry aspect of nsP2; in this part the enzymatic activities such as 
NTPase, RNA helicase and novel RNA annealing activity has been demon-
strated and conditions for their analysis have been optimized. This first part 
opens up avenues for second phase of the study which deals with the application 
of the gathered knowledge (and obtained assays) for understanding role of nsP2 
mutations in development of NCT phenotype of CHIKV. Below I would de-
scribe key findings which are central to the thesis in an objective manner. 
 
I) Structural homology modeling coupled with existing partial 3D-structural 
data suggest that CHIKV nsP2 (90 kDa) consists of five distinct domains. 
These are (enumerating from N-terminus of the protein) NTD, two RecA-
like domains, protease and MTL domain. Out of all the domains the NTD 
was predicted to be partially disordered. Its specific functionalities are 
unknown however it is likely that this domain with highly acidic pI ap-
parently interacts with the highly basic MTL domain. Experimental data 
obtained during this study indirectly supports this prediction.  
 
II) The structural predictions were validated by biochemical analysis of the 
CHIKV nsP2. For this the wt full length protein, its various mutants and 
truncated versions were expressed and purified to near homogeneity. 
Functional assays such as NTPase, helicase, RNA rewinding and protease 
assays were carried out.  
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III) CD spectroscopic analysis of the purified recombinant wt and various 
mutant and truncated versions suggest that nsP2 is largely an alpha heli-
cal protein however considerable portion of this protein was also sug-
gested to be loops. NsP2 was found to be tolerant to several mutations; 
however NCT mutation such as the 5A-PG could also contort the struc-
ture of nsP2 and deletion of either terminal domains resulted in 
aggregation of recombinant protein. 
 
IV) The results of NTPase and protease assays suggest that a wt native full 
length protein (without carrying any additional aa or missing few aa resi-
dues) is more active than its mutant forms; in several cases many-fold 
differences were observed. Furthermore, 5´-3´ RNA helicase activity and 
RNA strand annealing activity were exclusively properties of full length 
nsP2. This protein was also able to act on hybrid (RNA:DNA) substrates 
with a RNA tracking strand. The novel RNA strand annealing activity 
was most effective on substrates forming fork product. 
 
V) The results of NTPase assay indicate that a full length native nsP2 is 
much more active than the nsP2 containing a His-tag at its N-terminus. 
The protease assay carried out using substrates representing 2/3 site re-
vealed that in contrast to the closely related SFV nsP2 the nsP2 of 
CHIKV is tolerant to addition of two extra aa to its N-terminus.  
 
VI) The understanding accumulated from the basic biochemistry and 
enzymology of nsP2 was applied towards studying the NCT mutations 
identified in nsP2 region of CHIKV replicons adapted to non-cytotoxic 
growth in cell culture. These proteins were expressed, purified and ana-
lyzed. It was found that almost all the enzymatic activity such as NTPase, 
helicase and protease are affected by NCT related mutations. Though no 
clear correlation between decrement of these enzymatic activities and de-
velopment of NCT phenotype could be established nevertheless it could 
be proposed that NCT mutations act by compromising one or more en-
zymatic (and possibly non-enzymatic) activities of nsP2.  
 
VII) Finally, a number of ns-proteins from different alphaviruses were ex-
pressed, purified and used to raise polyclonal antisera. These antisera rep-
resent unique and efficient tools for detection of viral proteins using dif-
ferent immunological, such as western blot and immunofluorescence, 
methods. These samples were not only confined to our lab in Tartu but 
have been also shared globally with other laboratories studying alpha-
viruses. 
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The studies highlighted in this thesis represent important step towards better 
understanding molecular biology of alphaviruses. In addition, they also provide 
ground for application towards development of therapeutic compounds against 
this highly pathogenic virus. As always, not all important questions were 
answered and, as it is the case for many studies, new questions emerged. For 
example, currently we do not have any understanding about the residues in nsP2 
that contribute towards RNA binding. The answer to this type of question may 
also be able to clarify unanswered biological questions related to viral helicases 
in general: identification of RNA binding motif would able researchers to study 
role of helicase activity without compromising NTPase and RNA triphosphatase 
activities of the protein (which are inevitably inhibited if mutations are intro-
duced directly into NTPase active site). Determination of phenotype of such 
viruses would indeed be very important for dissection of RNA unwinding func-
tionalities towards viral replication.  It is also clear that in its current form the 
biochemical assays are robust and suitable for screening and collecting detailed 
information about effect of particular mutation on the nsP2 enzymatic activities 
or for screening small molecule inhibitors for their potential anti-enzymatic 
activity. However, for utilizing their full potential these assays need to be opti-
mized and adapted accordingly. For example, the current helicase and protease 
assays are gel based which limit the screening of large number of potential anti-
viral compounds under similar conditions and do not allow continuous meas-
urement of accumulation of reaction products. It can be envisioned that in the 
coming time these types of assays would be replaced by high throughput sys-
tems, for example utilizing FRET based principles and/or other molecular bea-
cons. Although work in this direction has been already started in our lab, de-
scribing results of these later studies is clearly beyond the scope of this thesis.  
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SUMMARY IN ESTONIAN 
Alfaviiruse nsP2 valk biokeemilisest vaatekohast: lugu 
mitmedomäänse valgu ensümaatilisest analüüsist 
Chikungunya viirus (CHIKV) on positiivse polaarsusega RNA genoomiga 
viirus mis kuulub alfaviiruste perekonda (sugukond Togaviridae). Sarnaselt 
teiste alfaviirustega levib CHIKV vektorputukate (enamasti Aedes perekonna 
moskiitod) vahendusel. Võrrelduna teiste alfaviirustega omab CHIKV suurt 
meditsiinilist tähtsust ning on viimase kümne aasta jooksul põhjustanud kaks 
suurt epideemiat: alates 2005 aastast India ookeani regioonis ja alates 2013 
hilissügisest Kariibi mere saartel ja Ameerikates. Mõlema epideemia käigus on 
haigestunud miljoneid inimesi. CHIKV infektsiooni iseloomustavad kõrge pa-
lavik, lööve ja eriti iseloomulikud on tugevad liigesevalud. Haigus muutub 
sageli krooniliseks ja liigesevalud võivad kesta kuid või isegi aastaid. CHIKV 
vastast vaktsiini ega spetsiifilist ravi ei ole.  
CHIKV genoom on umbes 12000 nukleotiidi jäägi pikkune. Nakatatud rakus 
sünteesitakse viiruse genoomselt RNAlt liitvalk, millest moodustuvad neli mit-
testruktuurset valku: nsP1, nsP2, nsP3 ja nsP4. Replikatsiooni protsessi käigus 
sünteesitakse ka genoomist lühem (subgenoomne) RNA millelt transleeritakse 
viiruse struktuursete valkude eelvalk. RNA replikatsioonis struktuursed valgud 
ei osale, seda protsessi viivad läbi mittestruktuursed valgud. Eriline roll selles 
protsessi kuulub nsP2 valgule. Ehkki see valk ei ole RNA polümeraas (see 
funktsioon on nsP4 valgul) on tal mitmed replikatsiooni protsessiks olulised 
aktiivsused. Selles väitekirjas käsitletud tööde alguses oli teada, et CHIKV nsP2 
omab oma N-terminaalses regioonis NTPaaset ja RNA trifosfataaset aktiivsust 
samal ajal kui valgu C-terminaalne ala omab proteaaset aktiivsust. Samuti 
eeldati, et nsP2 N-terminaalne region võib funktsioneerida kui RNA helikaas. 
Tänu sellistele funktsioonidele toimib nsP2 kui CHIKV replikatsiooniprotsessi 
peamine koordinaator.  
Nagu öeldud, CHIKV nsP2 valgu RNA helikaasse aktiivsuse kohta puudusid 
eksperimentaalsed andmed. Vastupidi, eelnevad tööd, mille eesmärkiks oli selle 
aktiivsuse demonstreerimine, ei suutnud seda aktiivsust tuvastada. Samuti ei 
olnud selge ei selle funktsiooni tähtsus viirusele ega ka see miks on ühes ja 
samas valgus olemas mitmed oma olemuselt väga erinevad aktiivsused: 
NTPaas, RNA trifiosfataas ja eeldatavasti RNA helikaas valgu N-terminaalses 
regioonis ja proteaas C-terminaalses alas. Leidmaks vastust nendele küsimustele 
uuriti nsP2 valgu järjestusi ja tema eeldatavat ruumilist struktuuri bioinformaa-
tilisi meetode kasutades, sellele järgnes valgu puhastamine ja tema funkt-
sioonide uurimine biokeemiliste meetodite abil. Kõige lõpuks uuriti nsP2 valgu 
funktsioone otse CHIKV nakatatud rakkudes kasutades selleks viiruse mutante, 
mis sisaldasid mutatsioone nsP2 valku kodeerivas alas.  
Läbiviidud molekulaarne modelleerimine näitas, et CHIKV nsP2 valgu esi-
mesed 470 aminohappe jääki pakitakse tõenäoliselt struktuuriks, milles on ole-
mas supersugukonda 1 (SF1) kuuluvatele helikaasidele iseloomulikud 
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struktuursed motiivid. Loodud CHIKV nsP2 N-terminaalse regiooni ruumiline 
mudel meenutab oma struktuurilt kõige enam tomati mosaiigiviirus RNA-
helikaasi struktuuri. Sellest struktuuris saab eristada kolme domääni. Kõige N-
terminaalsem nendest ei oma tõenäoliselt fikseeritud ruumilist struktuuri. Sel-
lele struktureerimata domäänile järgnevad kaks RecA-sarnast domääni, mis on 
iseloomulikud NTPaasidele ja RNA helikaasidele. Nendes domäänides paik-
nevad ka konserveerunud aminohappelised järjestused, mis leiduvad ka muudes 
SF1 RNA helikaasides. 
Biokeemiliste analüüside läbiviimiseks ekspresseriti ja puhastati nii nsP2, 
tema N-terminaalne (470-st aminohappe jäägist koosnev) fragment kui ka 
mitmed nende valkude mutantsed variandid. Nende rekombinatsete valkude 
biokeemiline analüüs võimaldas välja selgitada minimaalsed nõuded, mis on 
vajalikud nsP2 helikaasse aktiivsuse avaldumiseks. Nii selgus, et ainult täispikk 
nsP2 on RNA mis harutab RNA duplekseid lahti 5’- 3’ suunas. Näidati, et lisaks 
RNA helikaassele aktiivsusele on nsP2 valgul olemas ka RNA dupleksi moo-
dustamise funktsioon; ka see aktiivsus vajab valgu C-terminaalse regiooni ole-
masolu. Need andmed näitavad, et nn. helikaasi ja proteaasi regiooni olemasolu 
ühes valgus ei ole kaugeltki juhuslik ja et nende regioonide vahel toimuvad 
spetsiifilised interaktsioonid tagavad valgu võime läbi viia keerulisi protsesse. 
Siit saab teha oletuse, et need erinevate ensümaatiliste aktiivsustega domäänid 
on evolutsioneerunud koos ja moodustavad ühtse funktsionaalse terviku. 
NsP2 valgu N- ja C-terminaalsete domäänide ja tema N-terminaalse regiooni 
esimeste aminohappejääkide olulisust ensümaatilistele aktiivsustele uuriti nsP2 
valgu mutantseid variante kasutades. Sarnast lähenemist kasutati ka uurimaks 
mitmete nsP2 valgus paiknevate muudatuste mõju. Viimane on väga oluline, 
sest mutatsioonid, mis muudavad viiruse infektsiooni selgroogsete rakkude 
jaoks mittitsütotoksiliseks (metsikut tüüpi CHIKV infektsioon on nendele rak-
kudele surmav), paiknevad kõik nsP2 valku kodeerivas alas. Selline seose 
alfaviiruste mutantide mittetsütotoksilise fenotüübi ja nsP2 regioonis paiknevate 
mutatsioonide vahel on teada paljudest varasematest uuringutest, küll aga pol-
nud siiani teada, kas ja kuidas sellised mutatsioonid mõjutavad nsP2 valgu 
aktiivsuseid. Selles töö osas ekspresseriti ja puhastati mitmed nsP2 valgu mu-
tantsed vormid. Biofüüsikalisi meetode (CD spektroskoopia) kasutades näidati, 
et sellised muudatused ei põhjusta olulisi erinevusi valgu üldises struktuuris, st. 
mutantsed nsP2 vormid ei kujuta endast valesti pakitud valke. Analüüsid, mis 
viidi läbi kasutades nsP2 vorme, mis sisaldasid mittetsütotosilist fenotüüpi 
põhjustavaid mutatsioone, näitasid, et need mutatsioonid (ja nende kombi-
natsioonid) vähendavad kõiki nsP2 ensümaatilisi aktiivsuseid. Samas osutus 
konkreetse aktiivsuse vähenemise (või kadumise) korreleerimine mutantse 
viiruse fenotüübiga keeruliseks; kui üldse, siis näitas sellist korrelatsiooni vaid 
nsP2 RNA helikaasne aktiivsus. 
Üheks täiendavaks tööde suunaks kujunes ka alfaviiruste ns-valkude 
ekspresserimise ja puhastamise meetodite rakendamine erinevatest alfaviirustest 
pärinevate ns-valkude tootmiseks. Kõrge kvaliteediga (homogeensed ja 
enamasti lahustuvad) rekombinantsed valgud osutusid oluliseks vahendiks 
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efektiivsete polüklonaalsete antiseerumite saamiseks. Saadud töövahendid on 
palju efektiivsemad kui näiteks sünteetilise peptiide kasutades saadud antisee-
rumid. Seetõttu on need kasutusel paljudes laborites üle maailma kus neid ka-
sutatakse erinevate analüüside (nt. immunobloti, immuuno-fluorestsents ana-
lüüside ja immunosadestamiste) läbiviimiseks. Sellised töövahendid on juba 
võimaldanud välja selgitada palju uusi fakte CHIKV (ja alfaviiruste üldse) 
molekulaarbioloogia kohta. Ka strandardiseeritud meetodid aktiivse nsP2 valgu 
puhastamiseks ja selle ensümaatiliste aktiivsuste mõõtmiseks omavad praktilist 
väärtust. Muu hulgas saab selliseid töövahendeid kasutada loomaks skriining-
süsteeme, mis võimaldavad leida ja analüüsida nsP2 aktiivsuseid (ja koos 
sellega viiruse infektsiooni) mahasuruvaid ühendeid. 
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